Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Completed

Conditions: Recurrent Squamous Cell Lung Carcinoma
Stage IV Squamous Cell Lung Carcinoma AJCC v7

Interventions: Drug: Erlotinib Hydrochloride
Biological: Durvalumab
Drug: Docetaxel
Drug: FGFR Inhibitor AZD4547
Biological: Ipilimumab
Other: Laboratory Biomarker Analysis
Drug: Palbociclib
Drug: Taselisib
Biological: Nivolumab
Biological: Rilotumumab
Other: Pharmacological Study
Drug: Talazoparib
Biological: Tremelimumab

Registration Number: NCT02154490

Lead Sponsor: SWOG Cancer Research Network

Brief Summary: This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid ?Master Protocol? (S1400). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes a ?non-match? sub-study which will include all screened patients not eligible for any of the biomarker-driven sub-studies. This sub-study will compare a non-match therapy to standard of care also with the goal of approval.

Detailed Description: PRIMARY OBJECTIVES:

Screening component:

I. To establish a National Clinical Trials Network (NCTN) mechanism for genomically screening large but homogeneous cancer populations and subsequently assigning and accruing simultaneously to a multi-sub-study ?Master Protocol.? II. To evaluate the screen success rate defined as the percentage of screened patients that register for a therapeutic sub-study.

Sub-study-specific Objectives:

Design #1: Phase II/III Design:

III. To evaluate if there is sufficient evidence to continue to the Phase III component of the sub-study by comparing investigator-assessed progression-free survival (IA-PFS) between investigational therapy versus standard therapy (SoC) in patients with advanced stage refractory squamous cell carcinoma (SCCA) of the lung. (Phase II) IV. To determine if there is both a statistically and clinically-meaningful difference in IA-PFS among advanced stage refractory SCCA of the lung randomized to receive investigational therapy versus SoC. (Phase III) V. To compare overall survival (OS) in patients with advanced stage refractory SCCA of the lung randomized to investigational therapy versus SoC. (Phase III)

Design #2: Phase II followed by Phase III (Sequential Phase II to Phase III):

VI. To evaluate the objective response rate (confirmed and unconfirmed, complete and partial). (Phase II) VII. To determine if there is both a statistically and clinically-meaningful difference in IA-PFS among advanced stage refractory SCCA of the lung randomized to receive investigational therapy versus SoC. (Phase III) VIII. To compare overall survival (OS) in patients with advanced stage refractory SCCA of the lung randomized to investigational therapy versus SoC. (Phase III)

SECONDARY OBJECTIVES:

Sub-study-specific Objectives:

Design #1: Phase II/III Design:

I. To compare response rates (confirmed and unconfirmed, complete and partial responses) among patients randomized to receive investigational therapy versus SoC. (Phase II) II. To evaluate the frequency and severity of toxicities associated with investigational therapy versus SoC. (Phase II) III. To evaluate the duration of response (DoR) among patients who achieve a complete response (CR) or a partial response (PR) by Response Evaluation Criteria in Solid Tumors (RECIST) (1.1). (Phase II) III. To compare the response rates (confirmed and unconfirmed, complete and partial) among patients randomized to receive investigational therapy versus SoC. (Phase III) IV. To evaluate the frequency and severity of toxicities associated with investigational therapy versus SoC. (Phase III)

Design #2: Phase II followed by Phase III (Sequential Phase II to Phase III):

V. To evaluate PFS and OS with investigational therapy. (Phase II) VI. To evaluate the DoR among patients who achieve a CR or PR (confirmed and unconfirmed) by RECIST 1.1. (Phase II) VII. To evaluate the frequency and severity of toxicities associated with investigational therapy. (Phase II) VIII. To compare the response rates (confirmed and unconfirmed, complete and partial) among patients randomized to receive investigational therapy versus SoC. (Phase III) IX. To evaluate the frequency and severity of toxicities associated with investigational therapy versus SoC. (Phase III)

TERTIARY OBJECTIVES:

I. To evaluate the treatment arm randomization acceptance rate (TARAR) within each treatment arm of each sub-study defined as the percentage of patients randomized to a treatment arm that receive any protocol treatment. (Design #1: Phase II/III Design) II. To identify additional predictive tumor/blood biomarkers that may modify response or define resistance to the targeted therapy (TT)/targeted therapy combination (TTC) beyond the chosen biomarker for biomarker-driven sub-studies.

III. To evaluate potentially predictive biomarkers for non-match therapy (NMT) in the non-match studies.

IV. To identify potential resistance biomarkers at disease progression. V. To establish a tissue/ blood repository from patients with refractory SCCA of the lung.

OUTLINE: Patients are assigned to a biomarker-driven targeted therapy phase II study. If the objectives response rate observed is judged sufficient, patients proceed to a randomized phase III trial and are randomized to biomarker-driven targeted therapy or standard of care.

S1400A: (CLOSED TO ACCRUAL 12/18/2015) Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study are assigned to Arm I. Upon evidence of progression following discontinuation of 12 months of treatment, patients may restart treatment for up to 12 months with the same treatment guidelines followed during the initial 12-month treatment period (Arm III).

ARM I: (CLOSED TO ACCRUAL 12/18/2015) Patients receive anti-B7H1 monoclonal antibody MEDI4736 intravenously (IV) over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.

ARM II (CLOSED TO ACCRUAL 4/2015): Patients receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #2 4/22/15)

ARM III: For patients assigned to Arm 1, MEDI4736: Upon evidence of progression following discontinuation of 12 months of treatment, patients may restart treatment with Arm 3, MEDI4736 for up to 12 months with the same treatment guidelines followed during the initial 12-month treatment period. Patients will only be able to restart treatment once; thus a maximum of two 12-month periods will be allowed. Patients receive anti-B7H1 monoclonal antibody MEDI4736 intravenously (IV) over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.

S1400B (CLOSED TO ACCRUAL 12/12/2016): Patients with tumors positive for phosphoinositide 3-kinase (PI3KCA) are assigned to Arm I. Patients currently on Arm 2, docetaxel will be given the option to re-register to Arm 3, GCD-0032 after disease progression on current treatment (Arm III).

ARM I: Patients receive taselisib orally (PO) daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

ARM II (CLOSED TO ACCRUAL 12/18/2015): Patients receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)

ARM III: Re-Registration Treatment with GDC-0032 (Taselisib) Upon progression patients in Arm 2 may be eligible for Re-Registration to receive GDC-0032. Patients receive taselisib orally (PO) daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

S1400C (CLOSED TO ACCRUAL 09/01/2016): Patients with tumors positive for cyclin dependent kinase 4 (CDK4), cyclin D1 (CCND1), cyclin D2 (CCND2), and cyclin D3 (CCND3) are assigned to Arm I. Patients currently on Arm 2, docetaxel will be given the option to re-register to Arm 3, palbociclib, after disease progression on current treatment (Arm III).

ARM I: Patients receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.

ARM II (CLOSED TO ACCRUAL 12/18/2015): Patients receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)

ARM III: Re-Registration Treatment with Palbociclib. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive palbociclib. Patients receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.

S1400D (CLOSED TO ACCRUAL 10/31/2016): Patients with tumors positive for fibroblast growth factor receptor (FGFR) 1, FGFR2, and FGFR3 are assigned to Arm I. Patients currently on Arm 2, docetaxel will be given the option to re-register to Arm 3, AZD4547, after disease progression on current treatment (Arm III).

ARM I: Patients receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

ARM II (CLOSED TO ACCRUAL 12/18/2015): Patients receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)

ARM III: Re-Registration Treatment with AZD4547. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive AZD4547. Patients receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

S1400E (CLOSED TO ACCRUAL 11/25/2014): Patients with tumors positive for met proto-oncogene (MET) are randomized to 1 of 2 treatment arms. (permanently closed to accrual on 11/25/14)

ARM I: Patients receive rilotumumab IV on day 1 and erlotinib hydrochloride PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

ARM II: Patients receive erlotinib hydrochloride PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

S1400F: Patients with disease progression during or after prior anti-PD-1 or anti-PD-L1 antibody monotherapy as their most recent line of treatment receive durvalumab (IV over 60 minutes) and tremelimumab (IV over 60 minutes) on day 1 for courses 1-4 and durvalumab IV alone on day 1 of course 5 and subsequent courses until disease progression or unacceptable toxicity. Courses repeat every 28 days.

S1400G: Patients with tumors positive for homologous recombination repair deficiency receive talazoparib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

S1400I: Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study are randomized to 1 of 2 treatment arms.

ARM I: Patients receive nivolumab IV over 30 minutes on day 1 and ipilimumab IV over 60 minutes on day 1 of every third course. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.

ARM II: Patients receive nivolumab IV over 30 minutes on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, all patients are followed up periodically for up to 3 years from date of screening registration.

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 1864

Inclusion Criteria

SCREENING/PRE-SCREENING REGISTRATION:
Patients must have pathologically proven squamous cell carcinoma (SCCA) cancer of the lung confirmed by tumor biopsy and/or fine-needle aspiration; disease must be stage IV SCCA, or recurrent; the primary diagnosis of SCCA should be established using the current World Health Organization (WHO)/International Association for the Study of Lung Cancer (IASLC)-classification of Thoracic Malignancies; the diagnosis is based on hematoxylin and eosin (H&E) stained slides with or without specific defined immunohistochemistry (IHC) characteristic (p40/p63 positive, transcription termination factor [TTF1] negative) if required for diagnosis; mixed histologies are not allowed
Patients must either be eligible to be screened at progression on prior treatment or to be pre-screened prior to progression on current treatment; patients will either consent to the screening consent or the pre-screening consent, not both; these criteria are:
- Screening at progression on prior treatment: to be eligible for screening at progression, patients must have received at least one line of systemic therapy for any stage of disease (stages I-IV) and must have progressed during or following their most recent line of therapy; for patients whose prior systemic therapy was for stage I-III disease only (i.e. patient has not received any treatment for stage IV or recurrent disease), the prior systemic therapy must have been a platinum-based chemotherapy regimen and disease progression on the platinum-based chemotherapy must have occurred within one year from the last date that patient received that therapy; for patients whose prior therapy was for stage IV or recurrent disease, the patient must have received at least one line of a platinum-based chemotherapy regimen or checkpoint inhibitor therapy (e.g. nivolumab or pembrolizumab)
- Pre-screening prior to progression on current treatment: to be eligible for pre-screening, current treatment must be for stage IV or recurrent disease and patient must have received at least one dose of the current regimen; patients must have previously received or currently be receiving a platinum-based chemotherapy regimen or checkpoint inhibitor therapy (e.g. nivolumab or pembrolizumab); patients on first-line platinum-based treatment are eligible upon receiving cycle 1, day 1 infusion; Note: patients will not receive their sub-study assignment until they progress and the S1400 Notice of Progression is submitted
Patients must have adequate tumor tissue available, defined as >= 20% tumor cells and >= 0.2 mm^3 tumor volume
- The local interpreting pathologist must review the specimen
- The pathologist must sign the S1400 Local Pathology Review Form confirming tissue adequacy prior to screening/pre-screening registration
- Patients must agree to have this tissue submitted to Foundation Medicine for common broad platform Clinical Laboratory Improvement Act (CLIA) biomarker profiling; if archival tumor material is exhausted, then a new fresh tumor biopsy that is formalin-fixed and paraffin-embedded (FFPE) must be obtained; a tumor block or FFPE slides 4-5 microns thick must be submitted; bone biopsies are not allowed; if FFPE slides are to be submitted, at least 12 unstained slides plus an H&E stained slide, or 13 unstained slides must be submitted; however it is strongly recommended that 20 FFPE slides be submitted; Note: previous next-generation deoxyribonucleic acid (DNA) sequencing (NGS) will be repeated if done outside this study for sub-study assignment; patients must agree to have any tissue that remains after NGS testing retained for the use of the translational medicine (TM) studies (if such TM studies are defined) within any sub-study the patient is enrolled in
Patients must not have a known epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) fusion; EGFR/ALK testing is not required prior to registration and is included in the Foundation Medicine Incorporated (FMI) testing for screening/prescreening
Patients must have Zubrod performance status 0-1 documented within 28 days prior to screening/pre-screening registration
Patients must also be offered participation in banking for future use of specimens
Patients must be willing to provide prior smoking history as required on the S1400 Onstudy Form
As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
SUB-STUDY REGISTRATION:
Patients whose biomarker profiling results indicate the presence of an EGFR mutation or echinoderm microtubule-associated protein-like 4 (EML4)/ALK fusion are not eligible
Patients must have progressed (in the opinion of the treating investigator) following the most recent line of therapy
Patients must not have received any prior systemic therapy (systemic chemotherapy, immunotherapy or investigational drug) within 21 days prior to sub-study registration; patients must have recovered (=< grade 1) from any side effects of prior therapy; patients must not have received any radiation therapy within 14 days prior to sub-study registration
Patients must have measurable disease documented by computed tomography (CT) or magnetic resonance imaging (MRI); the CT from a combined positron emission tomography (PET)/CT may be used to document only non-measurable disease unless it is of diagnostic quality; measurable disease must be assessed within 28 days prior to sub-study registration; pleural effusions, ascites and laboratory parameters are not acceptable as the only evidence of disease; non-measurable disease must be assessed within 42 days prior to sub-study registration; all disease must be assessed and documented on the Baseline Tumor Assessment Form; patients whose only measurable disease is within a previous radiation therapy port must demonstrate clearly progressive disease (in the opinion of the treating investigator) prior to registration
Patients must have a CT or MRI scan of the brain to evaluate for central nervous system (CNS) disease within 42 days prior to sub-study registration; patient must not have leptomeningeal disease, spinal cord compression or brain metastases unless: (1) metastases have been locally treated and have remained clinically controlled and asymptomatic for at least 14 days following treatment and prior to registration, AND (2) patient has no residual neurological dysfunction and has been off corticosteroids for at least 24 hours prior to sub-study registration
Patient must have fully recovered from the effects of prior surgery at least 14 days prior to sub-study registration
Patients must not be planning to receive any concurrent chemotherapy, immunotherapy, biologic or hormonal therapy for cancer treatment; concurrent use of hormones for non-cancer-related conditions (e.g., insulin for diabetes and hormone replacement therapy) is acceptable
Absolute neutrophil count (ANC) >= 1,500/mcl obtained within 28 days prior to sub-study registration
Platelet count >= 100,000 mcl obtained within 28 days prior to sub-study registration
Hemoglobin >= 9 g/dL obtained within 28 days prior to sub-study registration
Serum bilirubin =< institutional upper limit of normal (IULN) within 28 days prior to sub-study registration; for patients with liver metastases, bilirubin must be =< 5 x IULN
Either alanine aminotransferase (ALT) or aspartate aminotransferase (AST) =< 2 x IULN within 28 days prior to sub-study registration (if both ALT and AST are done, both must be =< 2 IULN); for patients with liver metastases, either ALT or AST must be =< 5 x IULN (if both ALT and AST are done, both must be =< 5 x IULN)
Serum creatinine =< the IULN OR measured or calculated creatinine clearance >= 50 mL/min using the following Cockcroft-Gault Formula within 28 days prior to sub-study registration
Patients must have Zubrod performance status 0-1 documented within 28 days prior to sub-study registration
Patients must not have any grade III/IV cardiac disease as defined by the New York Heart Association Criteria (i.e., patients with cardiac disease resulting in marked limitation of physical activity or resulting in inability to carry on any physical activity without discomfort), unstable angina pectoris, and myocardial infarction within 6 months, or serious uncontrolled cardiac arrhythmia
Patients must not have documented evidence of acute hepatitis or have an active or uncontrolled infection
Patients with a known history of human immunodeficiency virus (HIV) seropositivity:
- Must have undetectable viral load using standard HIV assays in clinical practice
- Must have cluster of differentiation (CD)4 count >= 400/mcL
- Must not require prophylaxis for any opportunistic infections (i.e., fungal, Mycobacterium avium complex [mAC], or pneumocystis jiroveci pneumonia [PCP] prophylaxis)
- Must not be newly diagnosed within 12 months prior to sub-study registration
Prestudy history and physical exam must be obtained within 28 days prior to sub-study registration
No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years
Patients must not be pregnant or nursing; women/men of reproductive potential must have agreed to use an effective contraceptive method; a woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures
As part of the OPEN registration process the treating institution?s identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered into the system
Patients with impaired decision-making capacity are eligible as long as their neurological or psychological condition does not preclude their safe participation in the study (e.g., tracking pill consumption and reporting adverse events to the investigator)
Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines.

Exclusion Criteria

Not provided

Study Type: OBSERVATIONAL

Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
S1400E Arm II (CLOSED TO ACCRUAL 11/2014)	Erlotinib Hydrochloride	Patients with tumors positive for HGF/c-MET randomized to Arm II receive erlotinib hydrochloride PO daily. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (permanently closed to accrual on 11/25/14)
S1400A Arm III (MEDI4736)	Durvalumab	For patients assigned to Arm 1, MEDI4736: Upon evidence of progression following discontinuation of 12 months of treatment, patients may restart treatment with Arm 3, MEDI4736 for up to 12 months with the same treatment guidelines followed during the initial 12-month treatment period. Patients will only be able to restart treatment once; thus a maximum of two 12- month periods will be allowed. Patients registered to Arm III receive durvalumab IV over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.
S1400B Arm II (CLOSED TO ACCRUAL 12/18/2015)	Laboratory Biomarker Analysis	Patients with tumors positive for PI3KCA randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
S1400A Arm I (MEDI4736) (CLOSED TO ACCRUAL 12/2015)	Laboratory Biomarker Analysis	Patients with tumors that do not match one of the currently active drug-biomarker combinations randomized to Arm I receive anti-B7H1 monoclonal antibody MEDI4736 IV over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.
S1400A Arm III (MEDI4736)	Laboratory Biomarker Analysis	For patients assigned to Arm 1, MEDI4736: Upon evidence of progression following discontinuation of 12 months of treatment, patients may restart treatment with Arm 3, MEDI4736 for up to 12 months with the same treatment guidelines followed during the initial 12-month treatment period. Patients will only be able to restart treatment once; thus a maximum of two 12- month periods will be allowed. Patients registered to Arm III receive durvalumab IV over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.
S1400A Arm I (MEDI4736) (CLOSED TO ACCRUAL 12/2015)	Durvalumab	Patients with tumors that do not match one of the currently active drug-biomarker combinations randomized to Arm I receive anti-B7H1 monoclonal antibody MEDI4736 IV over 60 minutes on day 1. Treatment repeats every 14 days for 12 months in the absence of disease progression or unacceptable toxicity.
S1400B Arm I (taselisib) (CLOSED TO ACCRUAL 12/12/2016)	Laboratory Biomarker Analysis	Patients with tumors positive for PI3KCA randomized to Arm I receive taselisib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400A Arm II (CLOSED TO ACCRUAL 4/2015)	Laboratory Biomarker Analysis	Patients with tumors that do not match one of the currently active drug-biomarker combinations randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #2 4/22/15)
S1400B Arm III (taselisib) (CLOSED TO ACCRUAL 12/12/2016)	Laboratory Biomarker Analysis	Re-Registration Treatment with GDC-0032 (Taselisib). Upon progression patients in Arm 2 may be eligible for Re-Registration to receive GDC-0032. Patients will receive taselisib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400C Arm III (palbociclib)	Laboratory Biomarker Analysis	Re-Registration Treatment with palbociclib. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive palbociclib. Patients will receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
S1400B Arm II (CLOSED TO ACCRUAL 12/18/2015)	Docetaxel	Patients with tumors positive for PI3KCA randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
S1400C Arm I (palbociclib)	Laboratory Biomarker Analysis	Patients with tumors positive for CDK4/6, CCND1, CCND2, and CCND3 randomized to Arm I receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
S1400D Arm I (AZD4547) (CLOSED TO ACCRUAL 04/12/2017)	FGFR Inhibitor AZD4547	Patients with tumors positive for FGFR1, FGFR2, and FGFR3 randomized to Arm I receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400D Arm III (AZD4547) (CLOSED TO ACCRUAL 10/31/2016)	Laboratory Biomarker Analysis	Re-Registration Treatment with AZD4547. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive AZD4547. Patients will receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400I Arm I (nivolumab, ipilimumab)	Laboratory Biomarker Analysis	Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm I receive nivolumab IV over 30 minutes on day 1 and ipilimumab IV over 60 minutes on day 1 of every third cycle. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
S1400I Arm I (nivolumab, ipilimumab)	Nivolumab	Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm I receive nivolumab IV over 30 minutes on day 1 and ipilimumab IV over 60 minutes on day 1 of every third cycle. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
S1400I Arm II (nivolumab)	Laboratory Biomarker Analysis	Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm II receive nivolumab IV over 30 minutes on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
S1400E Arm I (CLOSED TO ACCRUAL 11/2014)	Erlotinib Hydrochloride	Patients with tumors positive for HGF/c-MET randomized to Arm I receive rilotumumab IV on day 1 and erlotinib hydrochloride PO daily. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (permanently closed to accrual on 11/25/14)
S1400E Arm I (CLOSED TO ACCRUAL 11/2014)	Rilotumumab	Patients with tumors positive for HGF/c-MET randomized to Arm I receive rilotumumab IV on day 1 and erlotinib hydrochloride PO daily. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (permanently closed to accrual on 11/25/14)
S1400E Arm II (CLOSED TO ACCRUAL 11/2014)	Laboratory Biomarker Analysis	Patients with tumors positive for HGF/c-MET randomized to Arm II receive erlotinib hydrochloride PO daily. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (permanently closed to accrual on 11/25/14)
S1400C Arm II (CLOSED TO ACCRUAL 12/18/2015)	Laboratory Biomarker Analysis	Patients with tumors positive for CDK4, CCND1, CCND2, and CCND3 randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
S1400D Arm III (AZD4547) (CLOSED TO ACCRUAL 10/31/2016)	FGFR Inhibitor AZD4547	Re-Registration Treatment with AZD4547. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive AZD4547. Patients will receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400F (durvalumab, tremelimumab)	Pharmacological Study	Patients with disease progression during or after prior anti-PD-1 or anti-PD-L1 antibody monotherapy as their most recent line of treatment receive durvalumab (IV over 60 minutes) and tremelimumab (IV over 60 minutes) on day 1 for courses 1-4 and durvalumab IV alone on day 1 of course 5 and subsequent courses until disease progression or unacceptable toxicity. Courses repeat every 28 days.
S1400G (talazoparib)	Laboratory Biomarker Analysis	Patients with tumors positive for homologous recombination repair deficiency receive talazoparib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400D Arm I (AZD4547) (CLOSED TO ACCRUAL 04/12/2017)	Laboratory Biomarker Analysis	Patients with tumors positive for FGFR1, FGFR2, and FGFR3 randomized to Arm I receive FGFR inhibitor AZD4547 PO BID on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400D Arm II (CLOSED TO ACCRUAL 10/31/2016)	Laboratory Biomarker Analysis	Patients with tumors positive for FGFR1, FGFR2, and FGFR3 randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
S1400E Arm I (CLOSED TO ACCRUAL 11/2014)	Laboratory Biomarker Analysis	Patients with tumors positive for HGF/c-MET randomized to Arm I receive rilotumumab IV on day 1 and erlotinib hydrochloride PO daily. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (permanently closed to accrual on 11/25/14)
S1400F (durvalumab, tremelimumab)	Laboratory Biomarker Analysis	Patients with disease progression during or after prior anti-PD-1 or anti-PD-L1 antibody monotherapy as their most recent line of treatment receive durvalumab (IV over 60 minutes) and tremelimumab (IV over 60 minutes) on day 1 for courses 1-4 and durvalumab IV alone on day 1 of course 5 and subsequent courses until disease progression or unacceptable toxicity. Courses repeat every 28 days.
S1400F (durvalumab, tremelimumab)	Durvalumab	Patients with disease progression during or after prior anti-PD-1 or anti-PD-L1 antibody monotherapy as their most recent line of treatment receive durvalumab (IV over 60 minutes) and tremelimumab (IV over 60 minutes) on day 1 for courses 1-4 and durvalumab IV alone on day 1 of course 5 and subsequent courses until disease progression or unacceptable toxicity. Courses repeat every 28 days.
S1400F (durvalumab, tremelimumab)	Tremelimumab	Patients with disease progression during or after prior anti-PD-1 or anti-PD-L1 antibody monotherapy as their most recent line of treatment receive durvalumab (IV over 60 minutes) and tremelimumab (IV over 60 minutes) on day 1 for courses 1-4 and durvalumab IV alone on day 1 of course 5 and subsequent courses until disease progression or unacceptable toxicity. Courses repeat every 28 days.
S1400G (talazoparib)	Pharmacological Study	Patients with tumors positive for homologous recombination repair deficiency receive talazoparib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400I Arm I (nivolumab, ipilimumab)	Ipilimumab	Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm I receive nivolumab IV over 30 minutes on day 1 and ipilimumab IV over 60 minutes on day 1 of every third cycle. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
S1400I Arm II (nivolumab)	Pharmacological Study	Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm II receive nivolumab IV over 30 minutes on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
S1400I Arm II (nivolumab)	Nivolumab	Patients with tumors that do not match one of the currently active drug-biomarker combinations or did not meet the eligibility requirements for that bio-marker driven sub-study randomized to Arm II receive nivolumab IV over 30 minutes on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
S1400A Arm II (CLOSED TO ACCRUAL 4/2015)	Docetaxel	Patients with tumors that do not match one of the currently active drug-biomarker combinations randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #2 4/22/15)
S1400C Arm I (palbociclib)	Palbociclib	Patients with tumors positive for CDK4/6, CCND1, CCND2, and CCND3 randomized to Arm I receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
S1400C Arm II (CLOSED TO ACCRUAL 12/18/2015)	Docetaxel	Patients with tumors positive for CDK4, CCND1, CCND2, and CCND3 randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
S1400C Arm III (palbociclib)	Palbociclib	Re-Registration Treatment with palbociclib. Upon progression patients in Arm 2 may be eligible for Re-Registration to receive palbociclib. Patients will receive palbociclib PO on days 1-21. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
S1400D Arm II (CLOSED TO ACCRUAL 10/31/2016)	Docetaxel	Patients with tumors positive for FGFR1, FGFR2, and FGFR3 randomized to Arm II receive docetaxel IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. (closed to accrual with Revision #3 12/18/2015)
S1400G (talazoparib)	Talazoparib	Patients with tumors positive for homologous recombination repair deficiency receive talazoparib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400B Arm I (taselisib) (CLOSED TO ACCRUAL 12/12/2016)	Taselisib	Patients with tumors positive for PI3KCA randomized to Arm I receive taselisib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
S1400B Arm III (taselisib) (CLOSED TO ACCRUAL 12/12/2016)	Taselisib	Re-Registration Treatment with GDC-0032 (Taselisib). Upon progression patients in Arm 2 may be eligible for Re-Registration to receive GDC-0032. Patients will receive taselisib PO daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.

Primary Outcome Measures

Name	Time	Method
Screen Success Rate	From date of registration to pre-screening or screening component until sub-study registration or death, a median of 3.5 months (IQR 2.0-6.0) in the pre-screened group and 0.9 months (IQR 0.7-1.1) in the screened at progression group.	Percentage of participants that registered to a therapeutic sub-study out of those who received a sub-study assignment. To receive a sub-study assignment, enrolled participants must have submitted tissue, had biomarker results, and been matched to a therapeutic sub-study.

Secondary Outcome Measures

Name	Time	Method

Trial Locations

Locations (1000): Riverside Methodist Hospital
🇺🇸
Columbus, Ohio, United States
Kaiser Permanente Los Angeles Medical Center
🇺🇸
Los Angeles, California, United States
Los Angeles County-USC Medical Center
🇺🇸
Los Angeles, California, United States
Emory University Hospital/Winship Cancer Institute
🇺🇸
Atlanta, Georgia, United States
Emory Saint Joseph's Hospital
🇺🇸
Atlanta, Georgia, United States
MedStar Union Memorial Hospital
🇺🇸
Baltimore, Maryland, United States
Johns Hopkins University/Sidney Kimmel Cancer Center
🇺🇸
Baltimore, Maryland, United States
University of Maryland/Greenebaum Cancer Center
🇺🇸
Baltimore, Maryland, United States
University of Pennsylvania/Abramson Cancer Center
🇺🇸
Philadelphia, Pennsylvania, United States
John H Stroger Jr Hospital of Cook County
🇺🇸
Chicago, Illinois, United States
Swedish Covenant Hospital
🇺🇸
Chicago, Illinois, United States
University of Chicago Comprehensive Cancer Center
🇺🇸
Chicago, Illinois, United States
Boston Medical Center
🇺🇸
Boston, Massachusetts, United States
Lyndon Baines Johnson General Hospital
🇺🇸
Houston, Texas, United States
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
🇺🇸
Houston, Texas, United States
Memorial Hermann Texas Medical Center
🇺🇸
Houston, Texas, United States
Cancer and Blood Specialists-Shadow
🇺🇸
Las Vegas, Nevada, United States
HealthCare Partners Medical Group Oncology/Hematology-San Martin
🇺🇸
Las Vegas, Nevada, United States
HealthCare Partners Medical Group Oncology/Hematology-Tenaya
🇺🇸
Las Vegas, Nevada, United States
Ann M Wierman MD LTD
🇺🇸
Las Vegas, Nevada, United States
Summerlin Hospital Medical Center
🇺🇸
Las Vegas, Nevada, United States
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
🇺🇸
Las Vegas, Nevada, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center
🇺🇸
Miami, Florida, United States
Richard L. Roudebush Veterans Affairs Medical Center
🇺🇸
Indianapolis, Indiana, United States
Sidney and Lois Eskenazi Hospital
🇺🇸
Indianapolis, Indiana, United States
IU Health Central Indiana Cancer Centers-East
🇺🇸
Indianapolis, Indiana, United States
Franciscan Health Indianapolis
🇺🇸
Indianapolis, Indiana, United States
Springmill Medical Center
🇺🇸
Indianapolis, Indiana, United States
Oncology Hematology Care Inc-Eden Park
🇺🇸
Cincinnati, Ohio, United States
Oncology Hematology Care Inc-Mercy West
🇺🇸
Cincinnati, Ohio, United States
Good Samaritan Hospital - Cincinnati
🇺🇸
Cincinnati, Ohio, United States
Oncology Hematology Care Inc - Anderson
🇺🇸
Cincinnati, Ohio, United States
Oncology Hematology Care Inc-Kenwood
🇺🇸
Cincinnati, Ohio, United States
Bethesda North Hospital
🇺🇸
Cincinnati, Ohio, United States
Oncology Hematology Care Inc-Blue Ash
🇺🇸
Cincinnati, Ohio, United States
TriHealth Cancer Institute-Westside
🇺🇸
Cincinnati, Ohio, United States
TriHealth Cancer Institute-Anderson
🇺🇸
Cincinnati, Ohio, United States
Kaiser Permanente-San Diego Mission
🇺🇸
San Diego, California, United States
Kaiser Permanente San Leandro
🇺🇸
San Leandro, California, United States
Abbott-Northwestern Hospital
🇺🇸
Minneapolis, Minnesota, United States
Hennepin County Medical Center
🇺🇸
Minneapolis, Minnesota, United States
Health Partners Inc
🇺🇸
Minneapolis, Minnesota, United States
California Pacific Medical Center-Pacific Campus
🇺🇸
San Francisco, California, United States
Kaiser Permanente-San Francisco
🇺🇸
San Francisco, California, United States
Meharry Medical College
🇺🇸
Nashville, Tennessee, United States
LDS Hospital
🇺🇸
Salt Lake City, Utah, United States
Henry Ford Hospital
🇺🇸
Detroit, Michigan, United States
Saint John Hospital and Medical Center
🇺🇸
Detroit, Michigan, United States
University of Oklahoma Health Sciences Center
🇺🇸
Oklahoma City, Oklahoma, United States
The University of Arizona Medical Center-University Campus
🇺🇸
Tucson, Arizona, United States
Mills-Peninsula Medical Center
🇺🇸
Burlingame, California, United States
Anchorage Associates in Radiation Medicine
🇺🇸
Anchorage, Alaska, United States
Alta Bates Summit Medical Center-Herrick Campus
🇺🇸
Berkeley, California, United States
PCR Oncology
🇺🇸
Arroyo Grande, California, United States
Anchorage Oncology Centre
🇺🇸
Anchorage, Alaska, United States
Kaiser Permanente - Harbor City
🇺🇸
Harbor City, California, United States
Sutter Auburn Faith Hospital
🇺🇸
Auburn, California, United States
Fowler Family Center for Cancer Care
🇺🇸
Jonesboro, Arkansas, United States
Alaska Breast Care and Surgery LLC
🇺🇸
Anchorage, Alaska, United States
Alaska Oncology and Hematology LLC
🇺🇸
Anchorage, Alaska, United States
Alaska Regional Hospital
🇺🇸
Anchorage, Alaska, United States
UC San Diego Moores Cancer Center
🇺🇸
La Jolla, California, United States
CHI Saint Vincent Cancer Center Hot Springs
🇺🇸
Hot Springs, Arkansas, United States
City of Hope Corona
🇺🇸
Corona, California, United States
Katmai Oncology Group
🇺🇸
Anchorage, Alaska, United States
Kaiser Permanente-Bellflower
🇺🇸
Bellflower, California, United States
Providence Alaska Medical Center
🇺🇸
Anchorage, Alaska, United States
Kaiser Permanente-Irvine
🇺🇸
Irvine, California, United States
AIS Cancer Center at San Joaquin Community Hospital
🇺🇸
Bakersfield, California, United States
Fairbanks Memorial Hospital
🇺🇸
Fairbanks, Alaska, United States
Kaiser Permanente-Deer Valley Medical Center
🇺🇸
Antioch, California, United States
City of Hope Antelope Valley
🇺🇸
Lancaster, California, United States
University of Arizona Cancer Center-North Campus
🇺🇸
Tucson, Arizona, United States
Kaiser Permanente-Santa Teresa-San Jose
🇺🇸
San Jose, California, United States
Kaiser Permanente-Fresno
🇺🇸
Fresno, California, United States
Fremont - Rideout Cancer Center
🇺🇸
Marysville, California, United States
Kaiser Permanente-Stockton
🇺🇸
Stockton, California, United States
Kaiser Permanente-Anaheim
🇺🇸
Anaheim, California, United States
Loma Linda University Medical Center
🇺🇸
Loma Linda, California, United States
Palo Alto Medical Foundation-Camino Division
🇺🇸
Mountain View, California, United States
Kaiser Permanente-Vallejo
🇺🇸
Vallejo, California, United States
University of Arkansas for Medical Sciences
🇺🇸
Little Rock, Arkansas, United States
Stanford Cancer Institute Palo Alto
🇺🇸
Palo Alto, California, United States
Saint Joseph Hospital - Orange
🇺🇸
Orange, California, United States
Rocky Mountain Cancer Centers-Boulder
🇺🇸
Boulder, Colorado, United States
Kaiser Permanente-Fontana
🇺🇸
Fontana, California, United States
Community Hospital of Monterey Peninsula
🇺🇸
Monterey, California, United States
City of Hope Comprehensive Cancer Center
🇺🇸
Duarte, California, United States
Washington Hospital
🇺🇸
Fremont, California, United States
Kaiser Permanente-Baldwin Park
🇺🇸
Baldwin Park, California, United States
Memorial Medical Center
🇺🇸
Springfield, Illinois, United States
Pacific Cancer Care-Monterey
🇺🇸
Monterey, California, United States
Sutter Roseville Medical Center
🇺🇸
Roseville, California, United States
Kaiser Permanente-Fremont
🇺🇸
Fremont, California, United States
Palo Alto Medical Foundation-Fremont
🇺🇸
Fremont, California, United States
Saint Jude Medical Center
🇺🇸
Fullerton, California, United States
Kaiser Permanente Medical Center - Santa Clara
🇺🇸
Santa Clara, California, United States
Kaiser San Rafael-Gallinas
🇺🇸
San Rafael, California, United States
Palo Alto Medical Foundation-Santa Cruz
🇺🇸
Santa Cruz, California, United States
USC / Norris Comprehensive Cancer Center
🇺🇸
Los Angeles, California, United States
Palo Alto Medical Foundation-Gynecologic Oncology
🇺🇸
Mountain View, California, United States
Kaiser Permanente-Roseville
🇺🇸
Roseville, California, United States
Sutter Cancer Research Consortium
🇺🇸
Novato, California, United States
Kaiser Permanente-Richmond
🇺🇸
Richmond, California, United States
Kaiser Permanente-Riverside
🇺🇸
Riverside, California, United States
Kaiser Permanente-Cadillac
🇺🇸
Los Angeles, California, United States
Kaiser Permanente-Oakland
🇺🇸
Oakland, California, United States
Sky Ridge Medical Center
🇺🇸
Lone Tree, Colorado, United States
UCHealth Memorial Hospital Central
🇺🇸
Colorado Springs, Colorado, United States
Kaiser Permanente-San Rafael
🇺🇸
San Rafael, California, United States
North Colorado Medical Center
🇺🇸
Greeley, Colorado, United States
Feather River Cancer Center
🇺🇸
Paradise, California, United States
City of Hope Rancho Cucamonga
🇺🇸
Rancho Cucamonga, California, United States
Smilow Cancer Hospital-Derby Care Center
🇺🇸
Derby, Connecticut, United States
Kaiser Permanente - Panorama City
🇺🇸
Panorama City, California, United States
Kaiser Permanente-San Diego Zion
🇺🇸
San Diego, California, United States
Palo Alto Medical Foundation Health Care
🇺🇸
Palo Alto, California, United States
Kaiser Permanente-Modesto
🇺🇸
Modesto, California, United States
Kaiser Permanente-San Marcos
🇺🇸
San Marcos, California, United States
City of Hope Mission Hills
🇺🇸
Mission Hills, California, United States
Saint Helena Hospital
🇺🇸
Saint Helena, California, United States
Kaiser Permanente-South San Francisco
🇺🇸
South San Francisco, California, United States
Northbay Cancer Center
🇺🇸
Vacaville, California, United States
Kaiser Permanente-Rock Creek
🇺🇸
Lafayette, Colorado, United States
Penrose-Saint Francis Healthcare
🇺🇸
Colorado Springs, Colorado, United States
Kaiser Permanente Medical Center-Vacaville
🇺🇸
Vacaville, California, United States
Sutter Solano Medical Center/Cancer Center
🇺🇸
Vallejo, California, United States
Parker Adventist Hospital
🇺🇸
Parker, Colorado, United States
Kaiser Permanente-Santa Rosa
🇺🇸
Santa Rosa, California, United States
Rocky Mountain Cancer Centers-Penrose
🇺🇸
Colorado Springs, Colorado, United States
Helen F Graham Cancer Center
🇺🇸
Newark, Delaware, United States
Palo Alto Medical Foundation-Sunnyvale
🇺🇸
Sunnyvale, California, United States
Medical Oncology Hematology Consultants PA
🇺🇸
Newark, Delaware, United States
UM Sylvester Comprehensive Cancer Center at Hollywood
🇺🇸
Hollywood, Florida, United States
Eastern Connecticut Hematology and Oncology Associates
🇺🇸
Norwich, Connecticut, United States
Yale-New Haven Hospital North Haven Medical Center
🇺🇸
North Haven, Connecticut, United States
Smilow Cancer Hospital-Orange Care Center
🇺🇸
Orange, Connecticut, United States
Sibley Memorial Hospital
🇺🇸
Washington, District of Columbia, United States
Comprehensive Cancer Care and Research Institute of Colorado LLC
🇺🇸
Englewood, Colorado, United States
Rocky Mountain Cancer Centers-Longmont
🇺🇸
Longmont, Colorado, United States
Kaiser Permanente-Walnut Creek
🇺🇸
Walnut Creek, California, United States
Kaiser Permanente-Lone Tree
🇺🇸
Lone Tree, Colorado, United States
Presbyterian Intercommunity Hospital
🇺🇸
Whittier, California, United States
Kaiser Permanente-Woodland Hills
🇺🇸
Woodland Hills, California, United States
Smilow Cancer Hospital-Waterbury Care Center
🇺🇸
Waterbury, Connecticut, United States
Gene Upshaw Memorial Tahoe Forest Cancer Center
🇺🇸
Truckee, California, United States
Poudre Valley Hospital
🇺🇸
Fort Collins, Colorado, United States
Rocky Mountain Cancer Centers-Sky Ridge
🇺🇸
Lone Tree, Colorado, United States
Christiana Care Health System-Wilmington Hospital
🇺🇸
Wilmington, Delaware, United States
McKee Medical Center
🇺🇸
Loveland, Colorado, United States
Hartford Hospital
🇺🇸
Hartford, Connecticut, United States
Smilow Cancer Hospital Care Center at Saint Francis
🇺🇸
Hartford, Connecticut, United States
Dekalb Medical Center
🇺🇸
Decatur, Georgia, United States
Smilow Cancer Hospital-Torrington Care Center
🇺🇸
Torrington, Connecticut, United States
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
🇺🇸
Savannah, Georgia, United States
Longmont United Hospital
🇺🇸
Longmont, Colorado, United States
Gwinnett Medical Center
🇺🇸
Lawrenceville, Georgia, United States
Danbury Hospital
🇺🇸
Danbury, Connecticut, United States
Midstate Medical Center
🇺🇸
Meriden, Connecticut, United States
Lawrence and Memorial Cancer Center
🇺🇸
Waterford, Connecticut, United States
Beebe Health Campus
🇺🇸
Rehoboth Beach, Delaware, United States
Kaiser Permanente-Capitol Hill Medical Center
🇺🇸
Washington, District of Columbia, United States
Rocky Mountain Cancer Centers-Parker
🇺🇸
Parker, Colorado, United States
Yale-New Haven Shoreline Medical Center
🇺🇸
Guilford, Connecticut, United States
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
🇺🇸
Hollywood, Florida, United States
Emory University Hospital Midtown
🇺🇸
Atlanta, Georgia, United States
Saint Alphonsus Cancer Care Center-Boise
🇺🇸
Boise, Idaho, United States
Phoebe Putney Memorial Hospital
🇺🇸
Albany, Georgia, United States
Mount Sinai Medical Center
🇺🇸
Miami Beach, Florida, United States
Veterans Affairs Connecticut Healthcare System-West Haven Campus
🇺🇸
West Haven, Connecticut, United States
Nanticoke Memorial Hospital
🇺🇸
Seaford, Delaware, United States
Kootenai Medical Center
🇺🇸
Coeur d'Alene, Idaho, United States
Harbin Clinic Medical Oncology and Clinical Research
🇺🇸
Rome, Georgia, United States
MedStar Georgetown University Hospital
🇺🇸
Washington, District of Columbia, United States
Saint Luke's Mountain States Tumor Institute
🇺🇸
Boise, Idaho, United States
Hawaii Oncology Inc-Pali Momi
🇺🇸
'Aiea, Hawaii, United States
The Cancer Center of Hawaii-Pali Momi
🇺🇸
'Aiea, Hawaii, United States
Sacred Heart Hospital
🇺🇸
Pensacola, Florida, United States
Memorial Hospital West
🇺🇸
Pembroke Pines, Florida, United States
Saint Luke's Mountain States Tumor Institute - Nampa
🇺🇸
Nampa, Idaho, United States
Northeast Georgia Medical Center-Gainesville
🇺🇸
Gainesville, Georgia, United States
Beebe Medical Center
🇺🇸
Lewes, Delaware, United States
Illinois CancerCare-Canton
🇺🇸
Canton, Illinois, United States
South Georgia Medical Center/Pearlman Cancer Center
🇺🇸
Valdosta, Georgia, United States
Piedmont Hospital
🇺🇸
Atlanta, Georgia, United States
Mount Sinai Comprehensive Cancer Center at Aventura
🇺🇸
Aventura, Florida, United States
Northside Hospital-Forsyth
🇺🇸
Cumming, Georgia, United States
Delaware Clinical and Laboratory Physicians PA
🇺🇸
Newark, Delaware, United States
Christiana Care Health System-Christiana Hospital
🇺🇸
Newark, Delaware, United States
Augusta University Medical Center
🇺🇸
Augusta, Georgia, United States
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
🇺🇸
Deerfield Beach, Florida, United States
Northside Hospital
🇺🇸
Atlanta, Georgia, United States
UM Sylvester Comprehensive Cancer Center at Plantation
🇺🇸
Plantation, Florida, United States
Memorial Health University Medical Center
🇺🇸
Savannah, Georgia, United States
John B Amos Cancer Center
🇺🇸
Columbus, Georgia, United States
Pali Momi Medical Center
🇺🇸
'Aiea, Hawaii, United States
Illinois CancerCare-Bloomington
🇺🇸
Bloomington, Illinois, United States
Saint Luke's Mountain States Tumor Institute-Twin Falls
🇺🇸
Twin Falls, Idaho, United States
Cancer Care Specialists of Illinois - Decatur
🇺🇸
Decatur, Illinois, United States
Centralia Oncology Clinic
🇺🇸
Centralia, Illinois, United States
Rush - Copley Medical Center
🇺🇸
Aurora, Illinois, United States
NorthShore University HealthSystem-Highland Park Hospital
🇺🇸
Highland Park, Illinois, United States
Hines Veterans Administration Hospital
🇺🇸
Hines, Illinois, United States
Saint Joseph Medical Center
🇺🇸
Tacoma, Washington, United States
Illinois CancerCare-Galesburg
🇺🇸
Galesburg, Illinois, United States
Illinois CancerCare-Macomb
🇺🇸
Macomb, Illinois, United States
Saint Luke's Mountain States Tumor Institute - Meridian
🇺🇸
Meridian, Idaho, United States
Carle on Vermilion
🇺🇸
Danville, Illinois, United States
Advocate Sherman Hospital
🇺🇸
Elgin, Illinois, United States
Mount Sinai Hospital Medical Center
🇺🇸
Chicago, Illinois, United States
Northwestern University
🇺🇸
Chicago, Illinois, United States
Saint Francis Hospital
🇺🇸
Greenville, South Carolina, United States
Crossroads Cancer Center
🇺🇸
Effingham, Illinois, United States
Kootenai Cancer Center
🇺🇸
Post Falls, Idaho, United States
NorthShore University HealthSystem-Glenbrook Hospital
🇺🇸
Glenview, Illinois, United States
AMITA Health Cancer Institute and Outpatient Center
🇺🇸
Hinsdale, Illinois, United States
Rush University Medical Center
🇺🇸
Chicago, Illinois, United States
Illinois CancerCare-Peru
🇺🇸
Peru, Illinois, United States
NorthShore University HealthSystem-Evanston Hospital
🇺🇸
Evanston, Illinois, United States
University of Chicago Medicine-Orland Park
🇺🇸
Orland Park, Illinois, United States
Valley Radiation Oncology
🇺🇸
Peru, Illinois, United States
Carle Physician Group-Effingham
🇺🇸
Effingham, Illinois, United States
Saint Luke's Mountain States Tumor Institute - Fruitland
🇺🇸
Fruitland, Idaho, United States
Kootenai Cancer Clinic
🇺🇸
Sandpoint, Idaho, United States
Illinois CancerCare-Kewanee Clinic
🇺🇸
Kewanee, Illinois, United States
Radiation Oncology of Northern Illinois
🇺🇸
Ottawa, Illinois, United States
Decatur Memorial Hospital
🇺🇸
Decatur, Illinois, United States
Northern Indiana Cancer Research Consortium
🇺🇸
South Bend, Indiana, United States
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
🇺🇸
Pekin, Illinois, United States
AMITA Health Alexian Brothers Medical Center
🇺🇸
Elk Grove Village, Illinois, United States
Carle Physician Group-Mattoon/Charleston
🇺🇸
Mattoon, Illinois, United States
Northwestern Medicine Cancer Center Warrenville
🇺🇸
Warrenville, Illinois, United States
Ingalls Memorial Hospital
🇺🇸
Harvey, Illinois, United States
Reid Health
🇺🇸
Richmond, Indiana, United States
Northwestern Medicine Cancer Center Delnor
🇺🇸
Geneva, Illinois, United States
Presence Saint Mary's Hospital
🇺🇸
Kankakee, Illinois, United States
Rush-Copley Healthcare Center
🇺🇸
Yorkville, Illinois, United States
Michiana Hematology Oncology PC-Plymouth
🇺🇸
Plymouth, Indiana, United States
OSF Saint Francis Radiation Oncology at Peoria Cancer Center
🇺🇸
Peoria, Illinois, United States
Illinois CancerCare-Princeton
🇺🇸
Princeton, Illinois, United States
Trinity Medical Center
🇺🇸
Moline, Illinois, United States
Hematology Oncology Associates of Illinois - Skokie
🇺🇸
Skokie, Illinois, United States
Joliet Oncology-Hematology Associates Limited
🇺🇸
Joliet, Illinois, United States
NorthShore Hematology Oncology-Libertyville
🇺🇸
Libertyville, Illinois, United States
Alegent Health Mercy Hospital
🇺🇸
Council Bluffs, Iowa, United States
Franciscan Health Mooresville
🇺🇸
Mooresville, Indiana, United States
Illinois CancerCare-Peoria
🇺🇸
Peoria, Illinois, United States
Springfield Clinic
🇺🇸
Springfield, Illinois, United States
Illinois CancerCare-Ottawa Clinic
🇺🇸
Ottawa, Illinois, United States
AMG Oncology - Naperville
🇺🇸
Naperville, Illinois, United States
Illinois Cancer Specialists-Niles
🇺🇸
Niles, Illinois, United States
Loyola University Medical Center
🇺🇸
Maywood, Illinois, United States
Memorial Hospital of South Bend
🇺🇸
South Bend, Indiana, United States
Good Samaritan Regional Health Center
🇺🇸
Mount Vernon, Illinois, United States
IU Health North Hospital
🇺🇸
Carmel, Indiana, United States
Memorial Regional Cancer Center Day Road
🇺🇸
Mishawaka, Indiana, United States
The Community Hospital
🇺🇸
Munster, Indiana, United States
UC Comprehensive Cancer Center at Silver Cross
🇺🇸
New Lenox, Illinois, United States
Michiana Hematology Oncology PC-Westville
🇺🇸
Westville, Indiana, United States
Methodist Medical Center of Illinois
🇺🇸
Peoria, Illinois, United States
OSF Saint Francis Medical Center
🇺🇸
Peoria, Illinois, United States
Central Illinois Hematology Oncology Center
🇺🇸
Springfield, Illinois, United States
Illinois CancerCare-Pekin
🇺🇸
Pekin, Illinois, United States
Southern Illinois University School of Medicine
🇺🇸
Springfield, Illinois, United States
Carle Cancer Center
🇺🇸
Urbana, Illinois, United States
The Carle Foundation Hospital
🇺🇸
Urbana, Illinois, United States
Cancer Care Specialists of Illinois-Swansea
🇺🇸
Swansea, Illinois, United States
Michiana Hematology Oncology PC-Elkhart
🇺🇸
Elkhart, Indiana, United States
IU Health Arnett Cancer Care
🇺🇸
Lafayette, Indiana, United States
Indiana University/Melvin and Bren Simon Cancer Center
🇺🇸
Indianapolis, Indiana, United States
IU Health Methodist Hospital
🇺🇸
Indianapolis, Indiana, United States
University of Iowa/Holden Comprehensive Cancer Center
🇺🇸
Iowa City, Iowa, United States
University of Kansas Hospital-Westwood Cancer Center
🇺🇸
Westwood, Kansas, United States
Kansas Institute of Medicine Cancer and Blood Center
🇺🇸
Lenexa, Kansas, United States
Michiana Hematology Oncology PC-South Bend
🇺🇸
South Bend, Indiana, United States
University of Kansas Cancer Center-West
🇺🇸
Kansas City, Kansas, United States
Mercy Medical Center-West Lakes
🇺🇸
West Des Moines, Iowa, United States
Cotton O'Neil Cancer Center / Stormont Vail Health
🇺🇸
Topeka, Kansas, United States
Cancer Center of Kansas - Dodge City
🇺🇸
Dodge City, Kansas, United States
Union Hospital
🇺🇸
Terre Haute, Indiana, United States
McFarland Clinic PC-Boone
🇺🇸
Boone, Iowa, United States
Saint Rose Ambulatory and Surgery Center
🇺🇸
Great Bend, Kansas, United States
King's Daughter's Medical Center
🇺🇸
Ashland, Kentucky, United States
Medical Oncology and Hematology Associates-West Des Moines
🇺🇸
Clive, Iowa, United States
Saint Francis Hospital and Medical Center - Topeka
🇺🇸
Topeka, Kansas, United States
Michiana Hematology Oncology PC-Mishawaka
🇺🇸
Mishawaka, Indiana, United States
Cancer Center of Kansas - Chanute
🇺🇸
Chanute, Kansas, United States
McFarland Clinic PC-Jefferson
🇺🇸
Jefferson, Iowa, United States
Hays Medical Center
🇺🇸
Hays, Kansas, United States
Mary Greeley Medical Center
🇺🇸
Ames, Iowa, United States
Cancer Center of Kansas - Wichita
🇺🇸
Wichita, Kansas, United States
Menorah Medical Center
🇺🇸
Overland Park, Kansas, United States
Mary Bird Perkins Cancer Center
🇺🇸
Baton Rouge, Louisiana, United States
Siouxland Regional Cancer Center
🇺🇸
Sioux City, Iowa, United States
University of Kansas Cancer Center
🇺🇸
Kansas City, Kansas, United States
Mercy Cancer Center-West Lakes
🇺🇸
Clive, Iowa, United States
Salina Regional Health Center
🇺🇸
Salina, Kansas, United States
University of Iowa Healthcare Cancer Services Quad Cities
🇺🇸
Bettendorf, Iowa, United States
Genesis Medical Center - East Campus
🇺🇸
Davenport, Iowa, United States
Cancer Center of Kansas - Fort Scott
🇺🇸
Fort Scott, Kansas, United States
Cancer Center of Kansas - Winfield
🇺🇸
Winfield, Kansas, United States
Baptist Health Corbin
🇺🇸
Corbin, Kentucky, United States
Newman Regional Health
🇺🇸
Emporia, Kansas, United States
Saint Catherine Hospital
🇺🇸
Garden City, Kansas, United States
Olathe Medical Center
🇺🇸
Olathe, Kansas, United States
McFarland Clinic PC - Ames
🇺🇸
Ames, Iowa, United States
Greater Regional Medical Center
🇺🇸
Creston, Iowa, United States
Trinity Regional Medical Center
🇺🇸
Fort Dodge, Iowa, United States
McFarland Clinic PC-Marshalltown
🇺🇸
Marshalltown, Iowa, United States
Methodist West Hospital
🇺🇸
West Des Moines, Iowa, United States
Minimally Invasive Surgery Hospital
🇺🇸
Lenexa, Kansas, United States
Cancer Center of Kansas-Liberal
🇺🇸
Liberal, Kansas, United States
Cancer Center of Kansas - Parsons
🇺🇸
Parsons, Kansas, United States
Cancer Center of Kansas - Pratt
🇺🇸
Pratt, Kansas, United States
University of Kansas Cancer Center-Overland Park
🇺🇸
Overland Park, Kansas, United States
McFarland Clinic PC-Trinity Cancer Center
🇺🇸
Fort Dodge, Iowa, United States
Mercy Medical Center - North Iowa
🇺🇸
Mason City, Iowa, United States
Cancer Center of Kansas - Newton
🇺🇸
Newton, Kansas, United States
Cancer Center of Kansas-Independence
🇺🇸
Independence, Kansas, United States
Cancer Center of Kansas - El Dorado
🇺🇸
El Dorado, Kansas, United States
Covenant Medical Center
🇺🇸
Waterloo, Iowa, United States
Central Care Cancer Center - Garden City
🇺🇸
Garden City, Kansas, United States
Central Care Cancer Center - Great Bend
🇺🇸
Great Bend, Kansas, United States
Cancer Center of Kansas-Manhattan
🇺🇸
Manhattan, Kansas, United States
Kansas City NCI Community Oncology Research Program
🇺🇸
Prairie Village, Kansas, United States
Cancer Center of Kansas - Salina
🇺🇸
Salina, Kansas, United States
Baptist Health Paducah
🇺🇸
Paducah, Kentucky, United States
Robert Veith MD LLC
🇺🇸
Metairie, Louisiana, United States
Cancer Center of Kansas - Wellington
🇺🇸
Wellington, Kansas, United States
Mary Bird Cancer Center/Saint Tammany Parish
🇺🇸
Covington, Louisiana, United States
University Health-Conway
🇺🇸
Monroe, Louisiana, United States
Ochsner Medical Center Kenner
🇺🇸
Kenner, Louisiana, United States
Saint Agnes Hospital
🇺🇸
Baltimore, Maryland, United States
MedStar Franklin Square Medical Center/Weinberg Cancer Institute
🇺🇸
Baltimore, Maryland, United States
Via Christi Regional Medical Center
🇺🇸
Wichita, Kansas, United States
York Hospital
🇺🇸
York, Maine, United States
Hematology/Oncology Clinic LLP
🇺🇸
Baton Rouge, Louisiana, United States
Louisiana Hematology Oncology Associates LLC
🇺🇸
Baton Rouge, Louisiana, United States
Cancer Center of Kansas-Wichita Medical Arts Tower
🇺🇸
Wichita, Kansas, United States
Lafayette Family Cancer Center-EMMC
🇺🇸
Brewer, Maine, United States
Greater Baltimore Medical Center
🇺🇸
Baltimore, Maryland, United States
Medical Center of Baton Rouge
🇺🇸
Baton Rouge, Louisiana, United States
Eastern Maine Medical Center
🇺🇸
Bangor, Maine, United States
Wichita NCI Community Oncology Research Program
🇺🇸
Wichita, Kansas, United States
Hardin Memorial Hospital
🇺🇸
Elizabethtown, Kentucky, United States
East Jefferson General Hospital
🇺🇸
Metairie, Louisiana, United States
Northshore Oncology Associates-Covington
🇺🇸
Covington, Louisiana, United States
Oncology Hematology Care Inc-Crestview
🇺🇸
Crestview Hills, Kentucky, United States
Baptist Health Madisonville/Merle Mahr Cancer Center
🇺🇸
Madisonville, Kentucky, United States
Harold Alfond Center for Cancer Care
🇺🇸
Augusta, Maine, United States
Sinai Hospital of Baltimore
🇺🇸
Baltimore, Maryland, United States
Kaiser Permanente-Woodlawn Medical Center
🇺🇸
Baltimore, Maryland, United States
Mary Bird Perkins Cancer Center/Terrebonne General Medical Center
🇺🇸
Houma, Louisiana, United States
Green Bay Oncology - Escanaba
🇺🇸
Escanaba, Michigan, United States
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford
🇺🇸
Sanford, Maine, United States
LSU Health Baton Rouge-North Clinic
🇺🇸
Baton Rouge, Louisiana, United States
Our Lady of the Lake Physicians Group - Medical Oncology
🇺🇸
Baton Rouge, Louisiana, United States
Lowell General Hospital
🇺🇸
Lowell, Massachusetts, United States
Lahey Hospital and Medical Center
🇺🇸
Burlington, Massachusetts, United States
Saint Joseph Mercy Oakland
🇺🇸
Pontiac, Michigan, United States
Dana-Farber/Brigham and Women's Cancer Center at South Shore
🇺🇸
South Weymouth, Massachusetts, United States
West Michigan Cancer Center
🇺🇸
Kalamazoo, Michigan, United States
IHA Hematology Oncology Consultants-Canton
🇺🇸
Canton, Michigan, United States
Essentia Health Cancer Center
🇺🇸
Duluth, Minnesota, United States
Weisberg Cancer Treatment Center
🇺🇸
Farmington Hills, Michigan, United States
Assarian Cancer Center
🇺🇸
Novi, Michigan, United States
Hematology Oncology Consultants-Clarkston
🇺🇸
Clarkston, Michigan, United States
Newland Medical Associates-Clarkston
🇺🇸
Clarkston, Michigan, United States
Oncology Center of The South Incorporated
🇺🇸
Houma, Louisiana, United States
Henry Ford Macomb Hospital-Clinton Township
🇺🇸
Clinton Township, Michigan, United States
Lake Huron Medical Center
🇺🇸
Port Huron, Michigan, United States
Penobscot Bay Medical Center
🇺🇸
Rockport, Maine, United States
Peninsula Regional Medical Center
🇺🇸
Salisbury, Maryland, United States
Beverly Hospital
🇺🇸
Beverly, Massachusetts, United States
Waldo County General Hospital
🇺🇸
Belfast, Maine, United States
Louisiana State University Health Sciences Center Shreveport
🇺🇸
Shreveport, Louisiana, United States
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
🇺🇸
Biddeford, Maine, United States
Mercy Hospital
🇺🇸
Coon Rapids, Minnesota, United States
Frederick Memorial Hospital
🇺🇸
Frederick, Maryland, United States
Kaiser Permanente-Gaithersburg Medical Center
🇺🇸
Gaithersburg, Maryland, United States
Henry Ford West Bloomfield Hospital
🇺🇸
West Bloomfield, Michigan, United States
Mercy Health Saint Mary's
🇺🇸
Grand Rapids, Michigan, United States
Providence Hospital-Southfield Cancer Center
🇺🇸
Southfield, Michigan, United States
Henry Ford Cancer Institute?Downriver
🇺🇸
Brownstown, Michigan, United States
Saint John's Hospital - Healtheast
🇺🇸
Maplewood, Minnesota, United States
Saint Joseph Mercy Brighton
🇺🇸
Brighton, Michigan, United States
Monroe Cancer Center
🇺🇸
Monroe, Michigan, United States
Bronson Battle Creek
🇺🇸
Battle Creek, Michigan, United States
Western Maryland Regional Medical Center
🇺🇸
Cumberland, Maryland, United States
Kaiser Permanente - Kensington Medical Center
🇺🇸
Kensington, Maryland, United States
Northwest Hospital Center
🇺🇸
Randallstown, Maryland, United States
Kaiser Permanente - Largo Medical Center
🇺🇸
Largo, Maryland, United States
William E Kahlert Regional Cancer Center/Sinai Hospital
🇺🇸
Westminster, Maryland, United States
Massachusetts General Hospital Cancer Center
🇺🇸
Boston, Massachusetts, United States
Addison Gilbert Hospital
🇺🇸
Gloucester, Massachusetts, United States
Beth Israel Deaconess Medical Center
🇺🇸
Boston, Massachusetts, United States
Simonds-Sinon Regional Cancer Center
🇺🇸
Fitchburg, Massachusetts, United States
Baystate Medical Center
🇺🇸
Springfield, Massachusetts, United States
IHA Hematology Oncology Consultants-Brighton
🇺🇸
Brighton, Michigan, United States
Spectrum Health at Butterworth Campus
🇺🇸
Grand Rapids, Michigan, United States
Henry Ford Medical Center-Fairlane
🇺🇸
Dearborn, Michigan, United States
Hickman Cancer Center
🇺🇸
Adrian, Michigan, United States
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional
🇺🇸
Milford, Massachusetts, United States
Saint Joseph Mercy Canton
🇺🇸
Canton, Michigan, United States
IHA Hematology Oncology Consultants-Chelsea
🇺🇸
Chelsea, Michigan, United States
Saint Joseph Mercy Chelsea
🇺🇸
Chelsea, Michigan, United States
Allegiance Health
🇺🇸
Jackson, Michigan, United States
Hurley Medical Center
🇺🇸
Flint, Michigan, United States
Beaumont Hospital-Dearborn
🇺🇸
Dearborn, Michigan, United States
Sparrow Hospital
🇺🇸
Lansing, Michigan, United States
Wayne State University/Karmanos Cancer Institute
🇺🇸
Detroit, Michigan, United States
Essentia Health Saint Mary's Medical Center
🇺🇸
Duluth, Minnesota, United States
Fairview-Southdale Hospital
🇺🇸
Edina, Minnesota, United States
Sanford Clinic North-Bemidgi
🇺🇸
Bemidji, Minnesota, United States
Marie Yeager Cancer Center
🇺🇸
Saint Joseph, Michigan, United States
Metro Health Hospital
🇺🇸
Wyoming, Michigan, United States
Fairview Ridges Hospital
🇺🇸
Burnsville, Minnesota, United States
Genesys Hurley Cancer Institute
🇺🇸
Flint, Michigan, United States
Borgess Medical Center
🇺🇸
Kalamazoo, Michigan, United States
Mid-Michigan Medical Center - Midland
🇺🇸
Midland, Michigan, United States
Hope Cancer Center
🇺🇸
Pontiac, Michigan, United States
University of Missouri - Ellis Fischel
🇺🇸
Columbia, Missouri, United States
New Ulm Medical Center
🇺🇸
New Ulm, Minnesota, United States
Saint Mary's of Michigan
🇺🇸
Saginaw, Michigan, United States
William Beaumont Hospital - Troy
🇺🇸
Troy, Michigan, United States
William Beaumont Hospital-Royal Oak
🇺🇸
Royal Oak, Michigan, United States
Lakeland Medical Center Saint Joseph
🇺🇸
Saint Joseph, Michigan, United States
Saint John Macomb-Oakland Hospital
🇺🇸
Warren, Michigan, United States
Henry Ford Medical Center-Columbus
🇺🇸
Novi, Michigan, United States
Munson Medical Center
🇺🇸
Traverse City, Michigan, United States
Unity Hospital
🇺🇸
Fridley, Minnesota, United States
Centerpoint Medical Center LLC
🇺🇸
Independence, Missouri, United States
Spectrum Health Reed City Hospital
🇺🇸
Reed City, Michigan, United States
Miller-Dwan Hospital
🇺🇸
Duluth, Minnesota, United States
Newland Medical Associates-Pontiac
🇺🇸
Pontiac, Michigan, United States
Saint Mary Mercy Hospital
🇺🇸
Livonia, Michigan, United States
IHA Hematology Oncology Consultants-Ann Arbor
🇺🇸
Ypsilanti, Michigan, United States
Mercy Health Mercy Campus
🇺🇸
Muskegon, Michigan, United States
Lakeland Hospital Niles
🇺🇸
Niles, Michigan, United States
Essentia Health Saint Joseph's Medical Center
🇺🇸
Brainerd, Minnesota, United States
Hutchinson Area Health Care
🇺🇸
Hutchinson, Minnesota, United States
Lake Region Healthcare Corporation-Cancer Care
🇺🇸
Fergus Falls, Minnesota, United States
Minnesota Oncology Hematology PA-Maplewood
🇺🇸
Maplewood, Minnesota, United States
Saint Francis Medical Center
🇺🇸
Cape Girardeau, Missouri, United States
Singing River Hospital
🇺🇸
Pascagoula, Mississippi, United States
Regions Hospital
🇺🇸
Saint Paul, Minnesota, United States
Saint Francis Regional Medical Center
🇺🇸
Shakopee, Minnesota, United States
Baptist Memorial Hospital and Cancer Center-Oxford
🇺🇸
Oxford, Mississippi, United States
Lakeview Hospital
🇺🇸
Stillwater, Minnesota, United States
Ridgeview Medical Center
🇺🇸
Waconia, Minnesota, United States
Metro Minnesota Community Oncology Research Consortium
🇺🇸
Saint Louis Park, Minnesota, United States
North Memorial Medical Health Center
🇺🇸
Robbinsdale, Minnesota, United States
United Hospital
🇺🇸
Saint Paul, Minnesota, United States
Minnesota Oncology Hematology PA-Woodbury
🇺🇸
Woodbury, Minnesota, United States
Rice Memorial Hospital
🇺🇸
Willmar, Minnesota, United States
Baptist Memorial Hospital and Cancer Center-Golden Triangle
🇺🇸
Columbus, Mississippi, United States
Central Care Cancer Center - Bolivar
🇺🇸
Bolivar, Missouri, United States
University of Mississippi Medical Center
🇺🇸
Jackson, Mississippi, United States
Southeast Cancer Center
🇺🇸
Cape Girardeau, Missouri, United States
Baptist Memorial Hospital and Cancer Center-Desoto
🇺🇸
Southhaven, Mississippi, United States
Parkland Health Center-Bonne Terre
🇺🇸
Bonne Terre, Missouri, United States
Saint Luke's Hospital
🇺🇸
Chesterfield, Missouri, United States
Siteman Cancer Center at West County Hospital
🇺🇸
Creve Coeur, Missouri, United States
Mercy Hospital Joplin
🇺🇸
Joplin, Missouri, United States
Capital Region Southwest Campus
🇺🇸
Jefferson City, Missouri, United States
Saint Luke's East - Lee's Summit
🇺🇸
Lee's Summit, Missouri, United States
Freeman Health System
🇺🇸
Joplin, Missouri, United States
The University of Kansas Cancer Center-Lee's Summit
🇺🇸
Lee's Summit, Missouri, United States
Siteman Cancer Center at Saint Peters Hospital
🇺🇸
Saint Peters, Missouri, United States
Mercy Clinic-Rolla-Cancer and Hematology
🇺🇸
Rolla, Missouri, United States
Saint Louis Cancer and Breast Institute-South City
🇺🇸
Saint Louis, Missouri, United States
Great Falls Clinic
🇺🇸
Great Falls, Montana, United States
Sainte Genevieve County Memorial Hospital
🇺🇸
Sainte Genevieve, Missouri, United States
Liberty Radiation Oncology Center
🇺🇸
Liberty, Missouri, United States
Delbert Day Cancer Institute at PCRMC
🇺🇸
Rolla, Missouri, United States
Billings Clinic Cancer Center
🇺🇸
Billings, Montana, United States
Washington University School of Medicine
🇺🇸
Saint Louis, Missouri, United States
Heartland Regional Medical Center
🇺🇸
Saint Joseph, Missouri, United States
Mercy Hospital Springfield
🇺🇸
Springfield, Missouri, United States
Saint Vincent Healthcare
🇺🇸
Billings, Montana, United States
Montana Cancer Consortium NCORP
🇺🇸
Billings, Montana, United States
Mercy Hospital Saint Louis
🇺🇸
Saint Louis, Missouri, United States
Missouri Baptist Sullivan Hospital
🇺🇸
Sullivan, Missouri, United States
CoxHealth South Hospital
🇺🇸
Springfield, Missouri, United States
Missouri Baptist Outpatient Center-Sunset Hills
🇺🇸
Sunset Hills, Missouri, United States
Community Hospital of Anaconda
🇺🇸
Anaconda, Montana, United States
Bozeman Deaconess Hospital
🇺🇸
Bozeman, Montana, United States
Saint James Community Hospital and Cancer Treatment Center
🇺🇸
Butte, Montana, United States
Benefis Healthcare- Sletten Cancer Institute
🇺🇸
Great Falls, Montana, United States
Saint Peter's Community Hospital
🇺🇸
Helena, Montana, United States
Comprehensive Cancer Centers of Nevada - Henderson
🇺🇸
Henderson, Nevada, United States
Las Vegas Cancer Center-Henderson
🇺🇸
Henderson, Nevada, United States
21st Century Oncology-Henderson
🇺🇸
Henderson, Nevada, United States
Midlands Community Hospital
🇺🇸
Papillion, Nebraska, United States
CHI Health Saint Francis
🇺🇸
Grand Island, Nebraska, United States
Faith Regional Health Services Carson Cancer Center
🇺🇸
Norfolk, Nebraska, United States
Great Plains Health Callahan Cancer Center
🇺🇸
North Platte, Nebraska, United States
Kalispell Regional Medical Center
🇺🇸
Kalispell, Montana, United States
Saint Elizabeth Regional Medical Center
🇺🇸
Lincoln, Nebraska, United States
Community Medical Hospital
🇺🇸
Missoula, Montana, United States
Nebraska Cancer Research Center
🇺🇸
Lincoln, Nebraska, United States
Southeast Nebraska Cancer Center
🇺🇸
Lincoln, Nebraska, United States
Saint Patrick Hospital - Community Hospital
🇺🇸
Missoula, Montana, United States
CHI Health Good Samaritan
🇺🇸
Kearney, Nebraska, United States
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
🇺🇸
Las Vegas, Nevada, United States
Regional West Medical Center Cancer Center
🇺🇸
Scottsbluff, Nebraska, United States
Nebraska Hematology and Oncology
🇺🇸
Lincoln, Nebraska, United States
Carson Tahoe Regional Medical Center
🇺🇸
Carson City, Nevada, United States
Comprehensive Cancer Centers of Nevada-Southeast Henderson
🇺🇸
Henderson, Nevada, United States
21st Century Oncology
🇺🇸
Las Vegas, Nevada, United States
Cancer and Blood Specialists-Henderson
🇺🇸
Henderson, Nevada, United States
Nevada Cancer Specialists-Saint Rose
🇺🇸
Henderson, Nevada, United States
Nevada Cancer Specialists?Oakey
🇺🇸
Las Vegas, Nevada, United States
Nevada Cancer Research Foundation CCOP
🇺🇸
Las Vegas, Nevada, United States
Cancer and Blood Specialists-Tenaya
🇺🇸
Las Vegas, Nevada, United States
Nevada Cancer Specialists-Tenaya
🇺🇸
Las Vegas, Nevada, United States
Cancer Therapy and Integrative Medicine
🇺🇸
Las Vegas, Nevada, United States
Comprehensive Cancer Centers of Nevada - Northwest
🇺🇸
Las Vegas, Nevada, United States
Renown Regional Medical Center
🇺🇸
Reno, Nevada, United States
Las Vegas Cancer Center-Medical Center
🇺🇸
Las Vegas, Nevada, United States
Comprehensive Cancer Centers of Nevada
🇺🇸
Las Vegas, Nevada, United States
Comprehensive Cancer Centers of Nevada - Central Valley
🇺🇸
Las Vegas, Nevada, United States
Radiation Oncology Associates
🇺🇸
Reno, Nevada, United States
Nevada Cancer Specialists-Fort Apache
🇺🇸
Las Vegas, Nevada, United States
Norris Cotton Cancer Center-Manchester
🇺🇸
Manchester, New Hampshire, United States
LRGHealthcare-Lakes Region General Hospital
🇺🇸
Laconia, New Hampshire, United States
The Valley Hospital-Luckow Pavilion
🇺🇸
Paramus, New Jersey, United States
Reno Oncology Consultants
🇺🇸
Reno, Nevada, United States
Jersey Shore Medical Center
🇺🇸
Neptune, New Jersey, United States
Alpine Hematology-Oncology
🇺🇸
Reno, Nevada, United States
Saint Mary's Regional Medical Center
🇺🇸
Reno, Nevada, United States
New Hampshire Oncology Hematology PA-Hooksett
🇺🇸
Hooksett, New Hampshire, United States
Dartmouth Hitchcock Medical Center
🇺🇸
Lebanon, New Hampshire, United States
Newark Beth Israel Medical Center
🇺🇸
Newark, New Jersey, United States
New Hampshire Oncology Hematology PA-Concord
🇺🇸
Concord, New Hampshire, United States
Valley Hospital
🇺🇸
Ridgewood, New Jersey, United States
Veterans Adminstration New Jersey Health Care System
🇺🇸
East Orange, New Jersey, United States
Virtua Memorial
🇺🇸
Mount Holly, New Jersey, United States
Riverview Medical Center/Booker Cancer Center
🇺🇸
Red Bank, New Jersey, United States
Virtua Voorhees
🇺🇸
Voorhees, New Jersey, United States
Memorial Medical Center - Las Cruces
🇺🇸
Las Cruces, New Mexico, United States
Valley Health System-Hematology/Oncology
🇺🇸
Westwood, New Jersey, United States
Roswell Park Cancer Institute
🇺🇸
Buffalo, New York, United States
State University of New York Upstate Medical University
🇺🇸
Syracuse, New York, United States
Orange Regional Medical Center
🇺🇸
Middletown, New York, United States
New York Oncology Hematology PC -Albany Medical Center
🇺🇸
Albany, New York, United States
New York-Presbyterian/Brooklyn Methodist Hospital
🇺🇸
Brooklyn, New York, United States
Mary Imogene Bassett Hospital
🇺🇸
Cooperstown, New York, United States
Mount Sinai Union Square
🇺🇸
New York, New York, United States
Glens Falls Hospital
🇺🇸
Glens Falls, New York, United States
Columbia University/Herbert Irving Cancer Center
🇺🇸
New York, New York, United States
Faxton-Saint Luke's Healthcare
🇺🇸
Utica, New York, United States
University of Rochester
🇺🇸
Rochester, New York, United States
Randolph Hospital
🇺🇸
Asheboro, North Carolina, United States
Novant Health Cancer Specialists-Matthews
🇺🇸
Matthews, North Carolina, United States
Stony Brook University Medical Center
🇺🇸
Stony Brook, New York, United States
Sanford Broadway Medical Center
🇺🇸
Fargo, North Dakota, United States
High Point Regional Hospital
🇺🇸
High Point, North Carolina, United States
Margaret R Pardee Memorial Hospital
🇺🇸
Hendersonville, North Carolina, United States
Southern Oncology Specialists-Huntersville
🇺🇸
Huntersville, North Carolina, United States
Cancer Care of Western North Carolina
🇺🇸
Asheville, North Carolina, United States
Cleveland Clinic Cancer Center Beachwood
🇺🇸
Beachwood, Ohio, United States
Strecker Cancer Center-Belpre
🇺🇸
Belpre, Ohio, United States
Novant Health Presbyterian Medical Center
🇺🇸
Charlotte, North Carolina, United States
Southern Oncology Specialists-Charlotte
🇺🇸
Charlotte, North Carolina, United States
Hendersonville Hematology and Oncology at Pardee
🇺🇸
Hendersonville, North Carolina, United States
Southeastern Medical Oncology Center-Goldsboro
🇺🇸
Goldsboro, North Carolina, United States
Mission Hospital Inc-Memorial Campus
🇺🇸
Asheville, North Carolina, United States
Lake Norman Hematology Oncology Specialists-Huntersville
🇺🇸
Huntersville, North Carolina, United States
Southeastern Medical Oncology Center-Jacksonville
🇺🇸
Jacksonville, North Carolina, United States
Cone Health Cancer Center at Alamance Regional
🇺🇸
Burlington, North Carolina, United States
Lake Norman Hematology Oncology Specialists-Mooresville
🇺🇸
Mooresville, North Carolina, United States
Oncology Specialists of Charlotte
🇺🇸
Charlotte, North Carolina, United States
Cone Health Cancer Center
🇺🇸
Greensboro, North Carolina, United States
Vidant Oncology-Kinston
🇺🇸
Kinston, North Carolina, United States
Cape Fear Valley Health System
🇺🇸
Fayetteville, North Carolina, United States
Wayne Memorial Hospital
🇺🇸
Goldsboro, North Carolina, United States
Duke University Medical Center
🇺🇸
Durham, North Carolina, United States
Southeastern Medical Oncology Center-Clinton
🇺🇸
Clinton, North Carolina, United States
Sanford Clinic North-Fargo
🇺🇸
Fargo, North Dakota, United States
Case Western Reserve University
🇺🇸
Cleveland, Ohio, United States
Cleveland Clinic Cancer Center/Fairview Hospital
🇺🇸
Cleveland, Ohio, United States
Matthews Radiation Oncology Center
🇺🇸
Matthews, North Carolina, United States
Geauga Hospital
🇺🇸
Chardon, Ohio, United States
Southeastern Medical Oncology Center-Wilson
🇺🇸
Wilson, North Carolina, United States
Duke Raleigh Hospital
🇺🇸
Raleigh, North Carolina, United States
FirstHealth of the Carolinas-Moore Regional Hospital
🇺🇸
Pinehurst, North Carolina, United States
Mercy Medical Center
🇺🇸
Canton, Ohio, United States
Sanford Bismarck Medical Center
🇺🇸
Bismarck, North Dakota, United States
Annie Penn Memorial Hospital
🇺🇸
Reidsville, North Carolina, United States
Trinity Cancer Care Center
🇺🇸
Minot, North Dakota, United States
Columbus Oncology and Hematology Associates Inc
🇺🇸
Columbus, Ohio, United States
Roger Maris Cancer Center
🇺🇸
Fargo, North Dakota, United States
UHHS-Chagrin Highlands Medical Center
🇺🇸
Beachwood, Ohio, United States
Aultman Health Foundation
🇺🇸
Canton, Ohio, United States
Indu and Raj Soin Medical Center
🇺🇸
Beavercreek, Ohio, United States
Adena Regional Medical Center
🇺🇸
Chillicothe, Ohio, United States
University of Cincinnati/Barrett Cancer Center
🇺🇸
Cincinnati, Ohio, United States
Ohio State University Comprehensive Cancer Center
🇺🇸
Columbus, Ohio, United States
MetroHealth Medical Center
🇺🇸
Cleveland, Ohio, United States
Columbus NCI Community Oncology Research Program
🇺🇸
Columbus, Ohio, United States
Cleveland Clinic Foundation
🇺🇸
Cleveland, Ohio, United States
Orion Cancer Care
🇺🇸
Findlay, Ohio, United States
Fairfield Medical Center
🇺🇸
Lancaster, Ohio, United States
Kettering Medical Center
🇺🇸
Kettering, Ohio, United States
Samaritan North Health Center
🇺🇸
Dayton, Ohio, United States
Cleveland Clinic Cancer Center Independence
🇺🇸
Independence, Ohio, United States
Doctors Hospital
🇺🇸
Columbus, Ohio, United States
Dayton Physicians LLC-Samaritan North
🇺🇸
Dayton, Ohio, United States
Grant Medical Center
🇺🇸
Columbus, Ohio, United States
Mount Carmel Health Center West
🇺🇸
Columbus, Ohio, United States
Good Samaritan Hospital - Dayton
🇺🇸
Dayton, Ohio, United States
The Mark H Zangmeister Center
🇺🇸
Columbus, Ohio, United States
Cleveland Clinic Cancer Center Mansfield
🇺🇸
Mansfield, Ohio, United States
Providence Oncology and Hematology Care Southeast
🇺🇸
Clackamas, Oregon, United States
Delaware Health Center-Grady Cancer Center
🇺🇸
Delaware, Ohio, United States
Mercy Hospital Oklahoma City
🇺🇸
Oklahoma City, Oklahoma, United States
Armes Family Cancer Center
🇺🇸
Findlay, Ohio, United States
Mercy Cancer Center-Elyria
🇺🇸
Elyria, Ohio, United States
Oncology Hematology Care Inc-Healthplex
🇺🇸
Fairfield, Ohio, United States
Hillcrest Hospital Cancer Center
🇺🇸
Mayfield Heights, Ohio, United States
Saint Ann's Hospital
🇺🇸
Westerville, Ohio, United States
The Toledo Hospital/Toledo Children's Hospital
🇺🇸
Toledo, Ohio, United States
Upper Valley Medical Center
🇺🇸
Troy, Ohio, United States
Grady Memorial Hospital
🇺🇸
Delaware, Ohio, United States
Blanchard Valley Hospital
🇺🇸
Findlay, Ohio, United States
Springfield Regional Medical Center
🇺🇸
Springfield, Ohio, United States
Marietta Memorial Hospital
🇺🇸
Marietta, Ohio, United States
Ireland Cancer Center Landerbrook Health Center
🇺🇸
Mayfield Heights, Ohio, United States
Toledo Clinic Cancer Centers-Maumee
🇺🇸
Maumee, Ohio, United States
Southern Ohio Medical Center
🇺🇸
Portsmouth, Ohio, United States
Cleveland Clinic Cancer Center Strongsville
🇺🇸
Strongsville, Ohio, United States
Toledo Clinic Cancer Centers-Toledo
🇺🇸
Toledo, Ohio, United States
Genesis Healthcare System Cancer Care Center
🇺🇸
Zanesville, Ohio, United States
Lake University Ireland Cancer Center
🇺🇸
Mentor, Ohio, United States
South Pointe Hospital
🇺🇸
Warrensville Heights, Ohio, United States
Licking Memorial Hospital
🇺🇸
Newark, Ohio, United States
Legacy Mount Hood Medical Center
🇺🇸
Gresham, Oregon, United States
University Pointe
🇺🇸
West Chester, Ohio, United States
University of Toledo
🇺🇸
Toledo, Ohio, United States
Oklahoma Cancer Specialists and Research Institute-Tulsa
🇺🇸
Tulsa, Oklahoma, United States
Clackamas Radiation Oncology Center
🇺🇸
Clackamas, Oregon, United States
Cleveland Clinic Wooster Family Health and Surgery Center
🇺🇸
Wooster, Ohio, United States
Bryn Mawr Hospital
🇺🇸
Bryn Mawr, Pennsylvania, United States
Geisinger Cancer Services-Pottsville
🇺🇸
Pottsville, Pennsylvania, United States
Geisinger Medical Oncology-Selinsgrove
🇺🇸
Selinsgrove, Pennsylvania, United States
UH Seidman Cancer Center at Saint John Medical Center
🇺🇸
Westlake, Ohio, United States
UHHS-Westlake Medical Center
🇺🇸
Westlake, Ohio, United States
University Hospitals Sharon Health Center
🇺🇸
Wadsworth, Ohio, United States
Christiana Care Health System-Concord Health Center
🇺🇸
Chadds Ford, Pennsylvania, United States
Cancer Centers of Southwest Oklahoma Research
🇺🇸
Lawton, Oklahoma, United States
Legacy Meridian Park Hospital
🇺🇸
Tualatin, Oregon, United States
Lehigh Valley Hospital-Cedar Crest
🇺🇸
Allentown, Pennsylvania, United States
Geisinger Medical Center
🇺🇸
Danville, Pennsylvania, United States
Lehigh Valley Hospital - Muhlenberg
🇺🇸
Bethlehem, Pennsylvania, United States
Bay Area Hospital
🇺🇸
Coos Bay, Oregon, United States
Providence Willamette Falls Medical Center
🇺🇸
Oregon City, Oregon, United States
Providence Newberg Medical Center
🇺🇸
Newberg, Oregon, United States
Salem Hospital
🇺🇸
Salem, Oregon, United States
Allegheny Valley Hospital
🇺🇸
Natrona Heights, Pennsylvania, United States
Ephrata Cancer Center
🇺🇸
Ephrata, Pennsylvania, United States
Ephrata Community Hospital
🇺🇸
Ephrata, Pennsylvania, United States
UPMC Pinnacle Cancer Center/Community Osteopathic Campus
🇺🇸
Harrisburg, Pennsylvania, United States
Geisinger Medical Center-Cancer Center Hazleton
🇺🇸
Hazleton, Pennsylvania, United States
Riddle Memorial Hospital
🇺🇸
Media, Pennsylvania, United States
Adams Cancer Center
🇺🇸
Gettysburg, Pennsylvania, United States
Cherry Tree Cancer Center
🇺🇸
Hanover, Pennsylvania, United States
Temple University Hospital
🇺🇸
Philadelphia, Pennsylvania, United States
Sechler Family Cancer Center
🇺🇸
Lebanon, Pennsylvania, United States
Geisinger Medical Oncology-Lewisburg
🇺🇸
Lewisburg, Pennsylvania, United States
Penn State Milton S Hershey Medical Center
🇺🇸
Hershey, Pennsylvania, United States
Lewistown Hospital
🇺🇸
Lewistown, Pennsylvania, United States
Paoli Memorial Hospital
🇺🇸
Paoli, Pennsylvania, United States
Community Medical Center
🇺🇸
Scranton, Pennsylvania, United States
Fox Chase Cancer Center
🇺🇸
Philadelphia, Pennsylvania, United States
Allegheny General Hospital
🇺🇸
Pittsburgh, Pennsylvania, United States
West Penn Hospital
🇺🇸
Pittsburgh, Pennsylvania, United States
University of Pittsburgh Cancer Institute (UPCI)
🇺🇸
Pittsburgh, Pennsylvania, United States
Chester County Hospital
🇺🇸
West Chester, Pennsylvania, United States
Pottstown Hospital
🇺🇸
Pottstown, Pennsylvania, United States
Penn State Health Saint Joseph Medical Center
🇺🇸
Reading, Pennsylvania, United States
Guthrie Medical Group PC-Robert Packer Hospital
🇺🇸
Sayre, Pennsylvania, United States
Reading Hospital
🇺🇸
West Reading, Pennsylvania, United States
WellSpan Health-York Hospital
🇺🇸
York, Pennsylvania, United States
AnMed Health Cancer Center
🇺🇸
Anderson, South Carolina, United States
Wexford Health and Wellness Pavilion
🇺🇸
Wexford, Pennsylvania, United States
Geisinger Medical Group
🇺🇸
State College, Pennsylvania, United States
UPMC Susquehanna
🇺🇸
Williamsport, Pennsylvania, United States
Geisinger Wyoming Valley/Henry Cancer Center
🇺🇸
Wilkes-Barre, Pennsylvania, United States
WellSpan Health-York Cancer Center
🇺🇸
York, Pennsylvania, United States
Lankenau Medical Center
🇺🇸
Wynnewood, Pennsylvania, United States
Miriam Hospital
🇺🇸
Providence, Rhode Island, United States
Gibbs Cancer Center-Gaffney
🇺🇸
Gaffney, South Carolina, United States
Gibbs Cancer Center-Pelham
🇺🇸
Greer, South Carolina, United States
Tidelands Georgetown Memorial Hospital
🇺🇸
Georgetown, South Carolina, United States
Greenville Health System Cancer Institute-Laurens
🇺🇸
Clinton, South Carolina, United States
Greenville Health System Cancer Institute-Easley
🇺🇸
Easley, South Carolina, United States
Avera Cancer Institute-Aberdeen
🇺🇸
Aberdeen, South Dakota, United States
Greenville Health System Cancer Institute-Butternut
🇺🇸
Greenville, South Carolina, United States
Greenville Health System Cancer Institute-Faris
🇺🇸
Greenville, South Carolina, United States
Saint Francis Cancer Center
🇺🇸
Greenville, South Carolina, United States
Greenville Health System Cancer Institute-Eastside
🇺🇸
Greenville, South Carolina, United States
Greenville Health System Cancer Institute-Seneca
🇺🇸
Seneca, South Carolina, United States
Greenville Health System Cancer Institute-Greer
🇺🇸
Greer, South Carolina, United States
MGC Hematology Oncology-Union
🇺🇸
Union, South Carolina, United States
Spartanburg Medical Center
🇺🇸
Spartanburg, South Carolina, United States
Greenville Health System Cancer Institute-Spartanburg
🇺🇸
Spartanburg, South Carolina, United States
Lowcountry Hematology Oncology PA-Mount Pleasant
🇺🇸
Mount Pleasant, South Carolina, United States
Lexington Medical Center
🇺🇸
West Columbia, South Carolina, United States
Sanford Cancer Center Oncology Clinic
🇺🇸
Sioux Falls, South Dakota, United States
Rapid City Regional Hospital
🇺🇸
Rapid City, South Dakota, United States
Parkland Memorial Hospital
🇺🇸
Dallas, Texas, United States
Vanderbilt Breast Center at One Hundred Oaks
🇺🇸
Nashville, Tennessee, United States
Vanderbilt University/Ingram Cancer Center
🇺🇸
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center Cool Springs
🇺🇸
Franklin, Tennessee, United States
Baptist Memorial Hospital and Cancer Center-Memphis
🇺🇸
Memphis, Tennessee, United States
Boston Baskin Cancer Center-Bartlett
🇺🇸
Bartlett, Tennessee, United States
Cookeville Regional Medical Center
🇺🇸
Cookeville, Tennessee, United States
The Methodist Hospital System
🇺🇸
Houston, Texas, United States
Bon Secours Saint Francis Medical Center
🇺🇸
Midlothian, Virginia, United States
University of Virginia Cancer Center
🇺🇸
Charlottesville, Virginia, United States
Thompson Cancer Survival Center
🇺🇸
Knoxville, Tennessee, United States
Utah Cancer Specialists-Salt Lake City
🇺🇸
Salt Lake City, Utah, United States
Thompson Oncology Group-Oak Ridge
🇺🇸
Oak Ridge, Tennessee, United States
Dixie Medical Center Regional Cancer Center
🇺🇸
Saint George, Utah, United States
MultiCare Auburn Medical Center
🇺🇸
Auburn, Washington, United States
Family Cancer Center-Memphis
🇺🇸
Memphis, Tennessee, United States
Thompson Cancer Survival Center - West
🇺🇸
Knoxville, Tennessee, United States
The Don and Sybil Harrington Cancer Center
🇺🇸
Amarillo, Texas, United States
UT Southwestern/Simmons Cancer Center-Dallas
🇺🇸
Dallas, Texas, United States
Baylor University Medical Center
🇺🇸
Dallas, Texas, United States
M D Anderson Cancer Center
🇺🇸
Houston, Texas, United States
Brooke Army Medical Center
🇺🇸
Fort Sam Houston, Texas, United States
Central Vermont Medical Center/National Life Cancer Treatment
🇺🇸
Berlin, Vermont, United States
University of Texas Medical Branch
🇺🇸
Galveston, Texas, United States
Sandra L Maxwell Cancer Center
🇺🇸
Cedar City, Utah, United States
Hematology Oncology Associates of Fredericksburg Inc
🇺🇸
Fredericksburg, Virginia, United States
Bon Secours Memorial Regional Medical Center
🇺🇸
Mechanicsville, Virginia, United States
Intermountain Medical Center
🇺🇸
Murray, Utah, United States
Ben Taub General Hospital
🇺🇸
Houston, Texas, United States
Utah Valley Regional Medical Center
🇺🇸
Provo, Utah, United States
Michael E DeBakey VA Medical Center
🇺🇸
Houston, Texas, United States
University of Texas Health Science Center at San Antonio
🇺🇸
San Antonio, Texas, United States
Covenant Medical Center-Lakeside
🇺🇸
Lubbock, Texas, United States
University Medical Center
🇺🇸
Lubbock, Texas, United States
UTMB Cancer Center at Victory Lakes
🇺🇸
League City, Texas, United States
Texas Tech University Health Sciences Center-Lubbock
🇺🇸
Lubbock, Texas, United States
Kaiser Permanente-Burke Medical Center
🇺🇸
Burke, Virginia, United States
University of Vermont College of Medicine
🇺🇸
Burlington, Vermont, United States
McKay-Dee Hospital Center
🇺🇸
Ogden, Utah, United States
Harrison HealthPartners Hematology and Oncology-Bremerton
🇺🇸
Bremerton, Washington, United States
American Fork Hospital / Huntsman Intermountain Cancer Center
🇺🇸
American Fork, Utah, United States
Logan Regional Hospital
🇺🇸
Logan, Utah, United States
Sovah Health Martinsville
🇺🇸
Martinsville, Virginia, United States
Huntsman Cancer Institute/University of Utah
🇺🇸
Salt Lake City, Utah, United States
Overlake Hospital Medical Center
🇺🇸
Bellevue, Washington, United States
Northwest Cancer Clinic
🇺🇸
Kennewick, Washington, United States
University of Vermont Medical Center
🇺🇸
Burlington, Vermont, United States
PeaceHealth Saint Joseph Medical Center
🇺🇸
Bellingham, Washington, United States
Lynchburg Hematology-Oncology Clinic
🇺🇸
Lynchburg, Virginia, United States
Harrison HealthPartners Hematology and Oncology-Poulsbo
🇺🇸
Poulsbo, Washington, United States
Kaiser Permanente Tysons Corner Medical Center
🇺🇸
McLean, Virginia, United States
MultiCare Gig Harbor Medical Park
🇺🇸
Gig Harbor, Washington, United States
Highline Medical Center-Main Campus
🇺🇸
Burien, Washington, United States
Peninsula Cancer Center
🇺🇸
Poulsbo, Washington, United States
Shenandoah Oncology PC
🇺🇸
Winchester, Virginia, United States
VCU Community Memorial Health Center
🇺🇸
South Hill, Virginia, United States
Kadlec Clinic Hematology and Oncology
🇺🇸
Kennewick, Washington, United States
Swedish Medical Center-Edmonds
🇺🇸
Edmonds, Washington, United States
Harrison Medical Center
🇺🇸
Bremerton, Washington, United States
Swedish Cancer Institute-Issaquah
🇺🇸
Issaquah, Washington, United States
Seattle Cancer Care Alliance at EvergreenHealth
🇺🇸
Kirkland, Washington, United States
Jefferson Healthcare
🇺🇸
Port Townsend, Washington, United States
MultiCare Good Samaritan Hospital
🇺🇸
Puyallup, Washington, United States
Providence Regional Cancer Partnership
🇺🇸
Everett, Washington, United States
Tacoma/Valley Radiation Oncology Centers-Gig Harbor
🇺🇸
Gig Harbor, Washington, United States
PeaceHealth Saint John Medical Center
🇺🇸
Longview, Washington, United States
Marshfield Clinic Cancer Center at Sacred Heart
🇺🇸
Eau Claire, Wisconsin, United States
Lakeview Medical Center-Marshfield Clinic
🇺🇸
Rice Lake, Wisconsin, United States
Skagit Valley Hospital Regional Cancer Care Center
🇺🇸
Mount Vernon, Washington, United States
Aurora Cancer Care-Kenosha South
🇺🇸
Kenosha, Wisconsin, United States
Marshfield Clinic
🇺🇸
Marshfield, Wisconsin, United States
Vince Lombardi Cancer Clinic - Oshkosh
🇺🇸
Oshkosh, Wisconsin, United States
The Alyce and Elmore Kraemer Cancer Care Center
🇺🇸
West Bend, Wisconsin, United States
Skagit Valley Hospital
🇺🇸
Mount Vernon, Washington, United States
Camden Clark Medical Center
🇺🇸
Parkersburg, West Virginia, United States
Fred Hutchinson Cancer Research Center
🇺🇸
Seattle, Washington, United States
Seattle Cancer Care Alliance
🇺🇸
Seattle, Washington, United States
Tacoma/Valley Radiation Oncology Centers-Puyallup
🇺🇸
Puyallup, Washington, United States
Virginia Mason Medical Center
🇺🇸
Seattle, Washington, United States
Swedish Medical Center-Ballard Campus
🇺🇸
Seattle, Washington, United States
Seattle Cancer Care Alliance at Northwest Hospital
🇺🇸
Seattle, Washington, United States
Edwards Comprehensive Cancer Center
🇺🇸
Huntington, West Virginia, United States
Saint Mary's Medical Center
🇺🇸
Huntington, West Virginia, United States
Kaiser Permanente Washington
🇺🇸
Seattle, Washington, United States
Northwest Medical Specialties PLLC
🇺🇸
Tacoma, Washington, United States
Swedish Medical Center-First Hill
🇺🇸
Seattle, Washington, United States
Tacoma/Valley Radiation Oncology Centers-Jackson Hall
🇺🇸
Tacoma, Washington, United States
Franciscan Research Center-Northwest Medical Plaza
🇺🇸
Tacoma, Washington, United States
Northwest NCI Community Oncology Research Program
🇺🇸
Tacoma, Washington, United States
University of Washington Medical Center
🇺🇸
Seattle, Washington, United States
West Virginia University Charleston Division
🇺🇸
Charleston, West Virginia, United States
West Virginia University Healthcare
🇺🇸
Morgantown, West Virginia, United States
MultiCare Tacoma General Hospital
🇺🇸
Tacoma, Washington, United States
PeaceHealth Southwest Medical Center
🇺🇸
Vancouver, Washington, United States
Tacoma/Valley Radiation Oncology Centers-Saint Joe's
🇺🇸
Tacoma, Washington, United States
Legacy Salmon Creek Hospital
🇺🇸
Vancouver, Washington, United States
Providence Saint Mary Regional Cancer Center
🇺🇸
Walla Walla, Washington, United States
United Hospital Center
🇺🇸
Bridgeport, West Virginia, United States
Marshfield Clinic-Chippewa Center
🇺🇸
Chippewa Falls, Wisconsin, United States
Wenatchee Valley Hospital and Clinics
🇺🇸
Wenatchee, Washington, United States
Fox Valley Hematology and Oncology SC-Appleton
🇺🇸
Appleton, Wisconsin, United States
HSHS Sacred Heart Hospital
🇺🇸
Eau Claire, Wisconsin, United States
Marshfield Clinic Cancer Center - Eau Claire
🇺🇸
Eau Claire, Wisconsin, United States
Langlade Hospital and Cancer Center
🇺🇸
Antigo, Wisconsin, United States
Mercy Health System
🇺🇸
Janesville, Wisconsin, United States
Saint Vincent Hospital Cancer Center Green Bay
🇺🇸
Green Bay, Wisconsin, United States
Aurora Cancer Care-Southern Lakes VLCC
🇺🇸
Burlington, Wisconsin, United States
Aurora Health Center-Fond du Lac
🇺🇸
Fond Du Lac, Wisconsin, United States
Green Bay Oncology at Saint Vincent Hospital
🇺🇸
Green Bay, Wisconsin, United States
Aurora Health Care Germantown Health Center
🇺🇸
Germantown, Wisconsin, United States
Aurora Cancer Care-Grafton
🇺🇸
Grafton, Wisconsin, United States
Holy Family Memorial Hospital
🇺🇸
Manitowoc, Wisconsin, United States
Green Bay Oncology Limited at Saint Mary's Hospital
🇺🇸
Green Bay, Wisconsin, United States
Aurora BayCare Medical Center
🇺🇸
Green Bay, Wisconsin, United States
Saint Vincent Hospital Cancer Center at Marinette
🇺🇸
Marinette, Wisconsin, United States
Vince Lombardi Cancer Clinic-Marinette
🇺🇸
Marinette, Wisconsin, United States
UW Cancer Center Johnson Creek
🇺🇸
Johnson Creek, Wisconsin, United States
Gundersen Lutheran Medical Center
🇺🇸
La Crosse, Wisconsin, United States
Marshfield Clinic - Ladysmith Center
🇺🇸
Ladysmith, Wisconsin, United States
Aurora Bay Area Medical Group-Marinette
🇺🇸
Marinette, Wisconsin, United States
ProHealth Oconomowoc Memorial Hospital
🇺🇸
Oconomowoc, Wisconsin, United States
Aurora Cancer Care-Racine
🇺🇸
Racine, Wisconsin, United States
Aurora Cancer Care-Milwaukee West
🇺🇸
Wauwatosa, Wisconsin, United States
Aspirus UW Cancer Center
🇺🇸
Wisconsin Rapids, Wisconsin, United States
Marshfield Medical Center
🇺🇸
Marshfield, Wisconsin, United States
Community Memorial Hospital
🇺🇸
Menomonee Falls, Wisconsin, United States
Ascension Saint Mary's Hospital
🇺🇸
Rhinelander, Wisconsin, United States
HSHS Saint Nicholas Hospital
🇺🇸
Sheboygan, Wisconsin, United States
Saint Mary's Hospital
🇺🇸
Rhinelander, Wisconsin, United States
Marshfield Clinic-Rice Lake Center
🇺🇸
Rice Lake, Wisconsin, United States
Marshfield Clinic-Minocqua Center
🇺🇸
Minocqua, Wisconsin, United States
ProHealth D N Greenwald Center
🇺🇸
Mukwonago, Wisconsin, United States
Cancer Center of Western Wisconsin
🇺🇸
New Richmond, Wisconsin, United States
Saint Vincent Hospital Cancer Center at Sturgeon Bay
🇺🇸
Sturgeon Bay, Wisconsin, United States
Green Bay Oncology - Sturgeon Bay
🇺🇸
Sturgeon Bay, Wisconsin, United States
Ascension Saint Michael's Hospital
🇺🇸
Stevens Point, Wisconsin, United States
UW Cancer Center at ProHealth Care
🇺🇸
Waukesha, Wisconsin, United States
Diagnostic and Treatment Center
🇺🇸
Weston, Wisconsin, United States
Saint Michael's Hospital
🇺🇸
Stevens Point, Wisconsin, United States
Marshfield Clinic-Wausau Center
🇺🇸
Wausau, Wisconsin, United States
Allan Blair Cancer Centre
🇨🇦
Regina, Saskatchewan, Canada
Saskatoon Cancer Centre
🇨🇦
Saskatoon, Saskatchewan, Canada
Vince Lombardi Cancer Clinic-Two Rivers
🇺🇸
Two Rivers, Wisconsin, United States
Aurora Medical Center in Summit
🇺🇸
Summit, Wisconsin, United States
Aspirus Regional Cancer Center
🇺🇸
Wausau, Wisconsin, United States
Marshfield Clinic - Weston Center
🇺🇸
Weston, Wisconsin, United States
Juravinski Cancer Centre at Hamilton Health Sciences
🇨🇦
Hamilton, Ontario, Canada
Saint Clare's Hospital
🇺🇸
Weston, Wisconsin, United States
Big Horn Basin Cancer Center
🇺🇸
Cody, Wyoming, United States
Welch Cancer Center
🇺🇸
Sheridan, Wyoming, United States
Rocky Mountain Oncology
🇺🇸
Casper, Wyoming, United States
Marshfield Clinic - Wisconsin Rapids Center
🇺🇸
Wisconsin Rapids, Wisconsin, United States
Ottawa Hospital and Cancer Center-General Campus
🇨🇦
Ottawa, Ontario, Canada
University Health Network-Princess Margaret Hospital
🇨🇦
Toronto, Ontario, Canada
University of Alabama at Birmingham Cancer Center
🇺🇸
Birmingham, Alabama, United States
Kaiser Permanente-Franklin
🇺🇸
Denver, Colorado, United States
SCL Health Saint Joseph Hospital
🇺🇸
Denver, Colorado, United States
Colorado Cancer Research Program NCORP
🇺🇸
Denver, Colorado, United States
Legacy Good Samaritan Hospital and Medical Center
🇺🇸
Portland, Oregon, United States
Providence Portland Medical Center
🇺🇸
Portland, Oregon, United States
Kaiser Permanente Northwest
🇺🇸
Portland, Oregon, United States
Providence Saint Vincent Medical Center
🇺🇸
Portland, Oregon, United States
Oregon Health and Science University
🇺🇸
Portland, Oregon, United States
Mayo Clinic
🇺🇸
Rochester, Minnesota, United States
Missouri Valley Cancer Consortium
🇺🇸
Omaha, Nebraska, United States
Nebraska Methodist Hospital
🇺🇸
Omaha, Nebraska, United States
Alegent Health Immanuel Medical Center
🇺🇸
Omaha, Nebraska, United States
Alegent Health Bergan Mercy Medical Center
🇺🇸
Omaha, Nebraska, United States
Nebraska Cancer Specialists - Omaha
🇺🇸
Omaha, Nebraska, United States
Alegent Health Lakeside Hospital
🇺🇸
Omaha, Nebraska, United States
Creighton University Medical Center
🇺🇸
Omaha, Nebraska, United States
University of Nebraska Medical Center
🇺🇸
Omaha, Nebraska, United States
Aurora Cancer Care-Milwaukee
🇺🇸
Milwaukee, Wisconsin, United States
Froedtert and the Medical College of Wisconsin
🇺🇸
Milwaukee, Wisconsin, United States
Aurora Saint Luke's Medical Center
🇺🇸
Milwaukee, Wisconsin, United States
Aurora Sinai Medical Center
🇺🇸
Milwaukee, Wisconsin, United States
University of Colorado Hospital
🇺🇸
Aurora, Colorado, United States
Moffitt Cancer Center
🇺🇸
Tampa, Florida, United States
Sutter Medical Center Sacramento
🇺🇸
Sacramento, California, United States
University of California Davis Comprehensive Cancer Center
🇺🇸
Sacramento, California, United States
Kaiser Permanente-South Sacramento
🇺🇸
Sacramento, California, United States
Kaiser Permanente - Sacramento
🇺🇸
Sacramento, California, United States
Saint Joseph Mercy Hospital
🇺🇸
Ann Arbor, Michigan, United States
Veteran's Administration Medical Center - Ann Arbor
🇺🇸
Ann Arbor, Michigan, United States
University of Michigan Comprehensive Cancer Center
🇺🇸
Ann Arbor, Michigan, United States
The James Graham Brown Cancer Center at University of Louisville
🇺🇸
Louisville, Kentucky, United States
Jewish Hospital
🇺🇸
Louisville, Kentucky, United States
Norton Hospital Pavilion and Medical Campus
🇺🇸
Louisville, Kentucky, United States
Baptist Health Louisville
🇺🇸
Louisville, Kentucky, United States
Norton Suburban Hospital and Medical Campus
🇺🇸
Louisville, Kentucky, United States
Saints Mary and Elizabeth Hospital
🇺🇸
Louisville, Kentucky, United States
Jewish Hospital Medical Center Northeast
🇺🇸
Louisville, Kentucky, United States
Hawaii Cancer Care Inc-POB II
🇺🇸
Honolulu, Hawaii, United States
Straub Clinic and Hospital
🇺🇸
Honolulu, Hawaii, United States
University of Hawaii Cancer Center
🇺🇸
Honolulu, Hawaii, United States
Hawaii Oncology Inc-Kuakini
🇺🇸
Honolulu, Hawaii, United States
Park Nicollet Clinic - Saint Louis Park
🇺🇸
Saint Louis Park, Minnesota, United States
Regional Hematology and Oncology PA
🇺🇸
Newark, Delaware, United States
Kaiser Permanente-Redwood City
🇺🇸
Redwood City, California, United States
Eisenhower Medical Center
🇺🇸
Rancho Mirage, California, United States
Medical Center of Central Georgia
🇺🇸
Macon, Georgia, United States
Illinois CancerCare-Carthage
🇺🇸
Carthage, Illinois, United States
The Hospital of Central Connecticut
🇺🇸
New Britain, Connecticut, United States
Illinois CancerCare-Eureka
🇺🇸
Eureka, Illinois, United States
Aurora West Allis Medical Center
🇺🇸
West Allis, Wisconsin, United States
Western Illinois Cancer Treatment Center
🇺🇸
Galesburg, Illinois, United States
Parkview Hospital Randallia
🇺🇸
Fort Wayne, Indiana, United States
Flaget Memorial Hospital
🇺🇸
Bardstown, Kentucky, United States
Green Bay Oncology - Oconto Falls
🇺🇸
Oconto Falls, Wisconsin, United States
Marshfield Clinic Stevens Point Center
🇺🇸
Stevens Point, Wisconsin, United States
Aurora Cancer Care-Waukesha
🇺🇸
Waukesha, Wisconsin, United States
ProHealth Waukesha Memorial Hospital
🇺🇸
Waukesha, Wisconsin, United States
Saint Luke's South Hospital
🇺🇸
Overland Park, Kansas, United States
Ochsner Health Center-Summa
🇺🇸
Baton Rouge, Louisiana, United States
University of Massachusetts Medical School
🇺🇸
Worcester, Massachusetts, United States
Saint Vincent Hospital Cancer Center at Saint Mary's
🇺🇸
Green Bay, Wisconsin, United States
Research Medical Center
🇺🇸
Kansas City, Missouri, United States
Truman Medical Center
🇺🇸
Kansas City, Missouri, United States
The University of Kansas Cancer Center-South
🇺🇸
Kansas City, Missouri, United States
Saint Luke's Hospital of Kansas City
🇺🇸
Kansas City, Missouri, United States
Kansas City Veterans Affairs Medical Center
🇺🇸
Kansas City, Missouri, United States
Heartland Hematology and Oncology Associates Incorporated
🇺🇸
Kansas City, Missouri, United States
The University of Kansas Cancer Center-North
🇺🇸
Kansas City, Missouri, United States
Bon Secours Saint Francis Hospital
🇺🇸
Charleston, South Carolina, United States
Lowcountry Hematology Oncology PA-West Ashley
🇺🇸
Charleston, South Carolina, United States
Roper Hospital
🇺🇸
Charleston, South Carolina, United States
Charleston Hematology Oncology Associates PA-Saint Francis
🇺🇸
Charleston, South Carolina, United States
Medical University of South Carolina
🇺🇸
Charleston, South Carolina, United States
Charleston Hematology Oncology Associates-Roper
🇺🇸
Charleston, South Carolina, United States
Smilow Cancer Center/Yale-New Haven Hospital
🇺🇸
New Haven, Connecticut, United States
Yale University
🇺🇸
New Haven, Connecticut, United States
Louisiana State University Health Science Center
🇺🇸
New Orleans, Louisiana, United States
Tulane University Health Sciences Center
🇺🇸
New Orleans, Louisiana, United States
University Medical Center New Orleans
🇺🇸
New Orleans, Louisiana, United States
LSU Healthcare Network/Saint Charles
🇺🇸
New Orleans, Louisiana, United States
Ochsner Medical Center Jefferson
🇺🇸
New Orleans, Louisiana, United States
Dell Seton Medical Center at The University of Texas
🇺🇸
Austin, Texas, United States
Bon Secours Saint Mary's Hospital
🇺🇸
Richmond, Virginia, United States
Virginia Cancer Institute
🇺🇸
Richmond, Virginia, United States
Virginia Commonwealth University/Massey Cancer Center
🇺🇸
Richmond, Virginia, United States
University of Florida Health Science Center - Gainesville
🇺🇸
Gainesville, Florida, United States
The Cancer Center of Hawaii-Liliha
🇺🇸
Honolulu, Hawaii, United States
Hawaii Oncology Inc-POB I
🇺🇸
Honolulu, Hawaii, United States
Queen's Medical Center
🇺🇸
Honolulu, Hawaii, United States
Hawaii Cancer Care Inc-Liliha
🇺🇸
Honolulu, Hawaii, United States
Kapiolani Medical Center for Women and Children
🇺🇸
Honolulu, Hawaii, United States
Kuakini Medical Center
🇺🇸
Honolulu, Hawaii, United States
Kaiser Permanente Moanalua Medical Center
🇺🇸
Honolulu, Hawaii, United States
Montefiore Medical Center-Einstein Campus
🇺🇸
Bronx, New York, United States
Montefiore Medical Center-Weiler Hospital
🇺🇸
Bronx, New York, United States
Montefiore Medical Center - Moses Campus
🇺🇸
Bronx, New York, United States
Bronx Veterans Administration Medical Center
🇺🇸
Bronx, New York, United States
Iowa Methodist Medical Center
🇺🇸
Des Moines, Iowa, United States
Iowa-Wide Oncology Research Coalition NCORP
🇺🇸
Des Moines, Iowa, United States
Medical Oncology and Hematology Associates-Des Moines
🇺🇸
Des Moines, Iowa, United States
Broadlawns Medical Center
🇺🇸
Des Moines, Iowa, United States
Medical Oncology and Hematology Associates-Laurel
🇺🇸
Des Moines, Iowa, United States
Mercy Medical Center - Des Moines
🇺🇸
Des Moines, Iowa, United States
Iowa Lutheran Hospital
🇺🇸
Des Moines, Iowa, United States
Baptist Health Lexington
🇺🇸
Lexington, Kentucky, United States
Saint Joseph Radiation Oncology Resource Center
🇺🇸
Lexington, Kentucky, United States
Saint Joseph Hospital East
🇺🇸
Lexington, Kentucky, United States
University of Kentucky/Markey Cancer Center
🇺🇸
Lexington, Kentucky, United States
University of New Mexico Cancer Center
🇺🇸
Albuquerque, New Mexico, United States
Lovelace Medical Center-Downtown
🇺🇸
Albuquerque, New Mexico, United States
Lovelace Medical Center-Saint Joseph Square
🇺🇸
Albuquerque, New Mexico, United States
New Mexico Oncology Hematology Consultants
🇺🇸
Albuquerque, New Mexico, United States
University of Wisconsin Hospital and Clinics
🇺🇸
Madison, Wisconsin, United States
Cross Cancer Institute
🇨🇦
Edmonton, Alberta, Canada
Avera Cancer Institute
🇺🇸
Sioux Falls, South Dakota, United States
Sanford USD Medical Center - Sioux Falls
🇺🇸
Sioux Falls, South Dakota, United States
Southwest General Health Center Ireland Cancer Center
🇺🇸
Middleburg Heights, Ohio, United States
Flower Hospital
🇺🇸
Sylvania, Ohio, United States
Via Christi Hospital-Pittsburg
🇺🇸
Pittsburg, Kansas, United States
Saint Charles Health System
🇺🇸
Bend, Oregon, United States
Cancer Center of Kansas-Kingman
🇺🇸
Kingman, Kansas, United States
Lawrence Memorial Hospital
🇺🇸
Lawrence, Kansas, United States
Knox Community Hospital
🇺🇸
Mount Vernon, Ohio, United States
North Coast Cancer Care
🇺🇸
Sandusky, Ohio, United States
Forbes Hospital
🇺🇸
Monroeville, Pennsylvania, United States
Billings Clinic-Cody
🇺🇸
Cody, Wyoming, United States
Cancer Center of Kansas - McPherson
🇺🇸
McPherson, Kansas, United States
Ireland Cancer Center at Firelands Regional Medical Center
🇺🇸
Sandusky, Ohio, United States
Vince Lombardi Cancer Clinic-Sheboygan
🇺🇸
Sheboygan, Wisconsin, United States
Robert Wood Johnson University Hospital Somerset
🇺🇸
Somerville, New Jersey, United States
Jefferson Hospital
🇺🇸
Jefferson Hills, Pennsylvania, United States
Arnot Ogden Medical Center/Falck Cancer Center
🇺🇸
Elmira, New York, United States
Missouri Baptist Medical Center
🇺🇸
Saint Louis, Missouri, United States
Rhode Island Hospital
🇺🇸
Providence, Rhode Island, United States

Related News

pmc.ncbi.nlm.nih.gov

9 years ago

Precision Oncology Medicine: The Clinical Relevance ...

Precision oncology leverages patient-specific biomarkers to optimize cancer treatment, utilizing genomic diagnostics and targeted therapeutics. Key advancements include companion diagnostics for drug-target pairs, multigene expression assays, and Next-Generation Sequencing for actionable mutations. Clinical trials like NCI-MATCH explore novel diagnostics and therapies, aiming to enhance precision medicine's clinical utility and future development.